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ABSTRACT 
We investigated the central carbon metabolism of Bacillus megaterium QM B1551 cells 
using various carbon substrates, long-term isotopic enrichment experiments with 
13
C-labeled 
carbons, metabolic flux analysis (MFA), and kinetic incorporation of 
13
C-labeled carbons. We 
determined that gluconate can be incorporated into the metabolic network structure of B. 
megaterium QM B1551, particularly when gluconate was present in the environment. It was 
shown in the same experiment that B. megaterium QM B1551 did not use the Entner-Doudoroff 
(ED) pathway for glucose (Gluc) metabolism, and instead relied primarily on the Embden-
Mayerhof-Parnas (EMP) and oxidative pentose phosphate (PP) pathways. The TCA cycle of this 
bacterium was incompletely bifurcated, although this bifurcation did not impede the ability of the 
bacterium to grow. There were bottlenecks in the fluxes from metabolite nodes alpha-
ketoglutarate (αKG) to succinate, from succinate to fumarate, and from oxaloacetate (OAA) to 
fumarate. This bifurcation was overcome with a direct input of substrate into the TCA cycle. The 
stereochemistry of citrate formation and cleavage was different compared to other bacterial flux 
studies (Sasnow et al., 2016). It was hypothesized that the carboxylation reaction which 
combines CO2 and pyruvate (PYR) added CO2 behind the third carbon position of PYR to form 
OAA. It was further hypothesized that OAA was flipped such that the fourth carbon position of 
OAA became the fourth carbon position of citrate. Finally, it was observed that B. megaterium 
QM B1551 had an early preference for glutamate catabolism in the TCA cycle, followed by a 
preference for Gluc catabolism across the metabolic network. I hope these results clarified 
contradictions in the literature, and that they will direct research to an optimized industrial use of 
this bacterium. 
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INTRODUCTION 
 
 Bacillus megaterium is an aerobic sporulating bacterium that is ubiquitous in a diverse 
range of environments, including soils, salt water, honey, and dried food (Vary, 1994; Vary et 
al., 2007). This bacterium is known to be endophytic, as it has been found to enter plants via 
junctions between root cells and slowly migrate into the intercellular spaces throughout the plant 
tissue (Liu et al., 2006). The metabolic products it excretes in the rhizosphere, such as antibiotics 
and siderophores, are thought to promote plant health (Eppinger et al., 2011; Santos et al., 2014). 
Several strains of B. megaterium have proven to be industrial staples in the large-scale 
production of biological products, due to their ready exportation of proteins without the 
accompanying secretion of endotoxins (Vary, 1994; Vary et al., 2007). Other applications of B. 
megaterium include bioremediation and the production of pharmaceutical compounds, 
recombinant proteins, vitamin B12, and fungicidal chemicals (Quinn, 1989; Vary, 1994; Vary et 
al., 2007). Numerous types of organic substrates including sugars and amino acids can be used as 
carbon sources to grow B. megaterium (Vary et al., 2007), and the types of substrates used have 
been shown to influence the biosynthetic pathways employed for product generation (Furch et 
al., 2007b; Vary et al., 2007; Santos et al., 2014; Aristilde et al., 2015; Kukurugya, 2017). 
Therefore, a comprehensive understanding of the cellular metabolism in B. megaterium is of 
particular interest. However, despite extensive genetic characterization of B. megaterium, 
detailed elucidation of its metabolic network structure and the cellular carbon fluxes is lacking. 
Here we seek to provide detailed insights into the sugar metabolism of B. megaterium 
QM B1551. Specifically, we explored the central carbon metabolism of B. megaterium when 
grown on glucose alone, or in a mixture with fructose and xylose. Since B. megaterium is both an 
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endophyte and a key player in the rhizosphere environment, it is critical to understand how this 
bacterium processes sugars common to the rhizosphere (Liu et al., 2006). Glucose is the sugar 
monomer of the polymers cellulose and starch, both of which are found in plant matter (KoÈgel-
Knabner, 2002). Quantifying how B. megaterium QM B1551 metabolizes glucose will provide a 
basis of comparison for other studies, because glucose has been established in literature as a 
principle substrate for characterizing the growth and functionality of a given bacterium. 
Similarly, fructose is a hexose sugar monomer common in plant tissue, and is usually found 
bound to glucose as sucrose. Xylose, a pentose sugar, is found in hemicellulose, an abundant 
component of plant cell walls (KoÈgel-Knabner, 2002). Understanding how B. megaterium QM 
B1551 utilizes these sugars when they are all present in a mixture will allow for better 
predictions of the bacterium’s metabolic ability to process these sugars simultaneously in the 
rhizosphere. It has been reported that adding supplementations of casamino acids to sugar media 
increases growth and protein production in B. megaterium cultures (Korneli, 2012; Marchland, 
2016). For completeness, bacterial growth was also characterized for a mixture of glucose and 
glutamate.  
 A model of the metabolic network was hypothesized based on the fully sequenced 
genome of B. megaterium QM B1551 (Eppinger et al., 2011; Kanehisa and Goto, 2000; 
Kanehisa et al., 2017). To date, this metabolic network has not been validated explicitly using 
carbon mapping techniques (Furch et al, 2007a; Furch et al., 2007b; Biedendieck et al., 2010). 
Most of what is known about carbon metabolism in Bacillus species is derived from studies on 
B. subtilis, a popular model organism for Gram-positive bacteria (Sauer et al., 1997; Dauner et 
al., 2001a; Dauner et al., 2001b). Thus, many of the metabolic network assumptions used to 
construct B. megaterium models are based on B. subtilis models and B. subtilis data. A few 
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strains of B. megaterium have been studied in the context of metabolic flux analysis, including 
MS941, WH323, and WH320, but all of these strains were mutants lacking specific functions 
within the metabolic network (Furch et al., 2007a). Therefore, while inferences about the 
metabolic network of B. megaterium QM B1551 were drawn from these other B. megaterium 
strains, the assumptions needed to be experimentally verified. 
It has been well established that B. megaterium undergoes glycolysis via the Embden-
Meyerhof-Parnas (EMP) pathway, which then feeds into the tricarboxylic acid (TCA) cycle 
(Vary, 2007; Furch et al., 2007; Sauer et al., 2008; Eppinger et al., 2011) (Fig. 1, 2). In the EMP 
pathway, glucose is first converted to glucose-6-phosphate (G6P), then its isomer fructose-6-
phosphate (F6P); it is next phosphorylated to fructose-bis-phosphate (FBP), and finally cleaved 
into dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (GAP) (Fig. 1). The 
EMP pathway metabolites can also contribute to the pentose phosphate (PP) pathway. The 
oxidative phase of the PP pathway involves first the conversion of G6P to 6-phosphogluconate 
(6-PG) (Fig. 1). The carbon in the first position of 6-PG is then cleaved, resulting in ribulose 5-
phosphate (Ru5P). In the nonoxidative phase of the PP pathway, Ru5P can interconvert to form 
ribose 5-phosphate (R5P) and xylulose 5-phosphate (Xu5P) (Fig. 1). A transketolase reaction 
then adds the carbons in the first and second position of Xu5P onto R5P, forming sedoheptulose 
7-phosphate (S7P) and GAP (Fig. 1). A second transketolase reaction can add the carbons in the 
first and second position of Xu5P before the first carbon position of erythrose 4-phosphate (E4P) 
to form F6P, while the last three carbons of Xu5P become GAP. A transaldolase reaction adds 
the carbons in the first three positions of F6P before the first carbon position of E4P to form S7P, 
and the last three carbons of F6P become GAP. The output of both the EMP and PP pathways, 
GAP, eventually generates pyruvate (PYR) to feed into the TCA cycle (Fig. 1, 2). Through 
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decarboxylation and carboxylation, PYR can form acetyl-co-enzyme A (Ac-CoA) and 
oxaloacetate (OAA), respectively (Fig. 2). In the former case, the third carbon of PYR is cleaved 
and lost as CO2, resulting in Ac-CoA (Sasnow et al., 2016). In the latter case, a CO2 is added to 
first carbon of PYR, resulting in OAA (Sasnow et al., 2016). In the first step of the TCA cycle, 
Ac-CoA is added to the third carbon of OAA to form citrate (Sasnow et al., 2016) (Fig. 2). 
Citrate undergoes a decarboxylation, in which the first carbon is lost as CO2 and alpha-
ketogluterate (αKG) is generated (Sasnow et al., 2016). In turn, the first carbon of αKG is 
decarboxylated to form succinate and CO2 (Sasnow et al., 2016) (Fig. 2). These reactions are 
considered irreversible (Sasnow et al., 2016). Succinate can be interconverted with fumarate, 
which in turn can be interconverted with malate (Fig. 2). Rounding out the TCA cycle, malate 
can either lose the carbon in its first position to form PYR, or can interconvert with OAA (Fig. 
2). Canonically, the TCA cycle is thought to proceed in this clockwise fashion from OAA to 
succinate to malate and back to OAA. 
There are conflicting results regarding the relative distribution of fluxes from G6P going 
towards either the EMP pathway or the PP pathway (Sauer et al., 1997, Dauner et al., 2001a; 
Tannlet et al., 2008; Furch et al., 2007a; Furch et al., 2007b). Some previous studies suggest that 
B. subtilis exhibits a higher degree of activity in the PP pathway than the EMP pathway (Sauer et 
al., 1997), while others have found the converse to be true (Dauner et al., 2001a; Tannlet et al., 
2008). Metabolic flux studies on B. megaterium have found that carbon-starved B. megaterium 
tends to utilize both the EMP pathway and PP pathway equally, while recombinant strains of B. 
megaterium encoding Thermobidfida fusca hydrolase (TFH) exhibit higher degrees of activity in 
the PP pathway only when the TFH-production genes are induced (Furch et al., 2007a; Furch et 
al., 2007b). These same studies have not provided a high resolution of fluxes through the TCA 
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cycle, and so the flux distribution between the TCA cycle nodes are relatively unexplored in 
Bacillus species (Furch et al., 2007a; Furch et al., 2007b) Specifically, the only TCA metabolites 
included in the previous model were malate, OAA, and a lumped grouping of organic acids 
(Furch et al., 2007a; Furch et al., 2007b).  
 
Figure 1. A simplified model network of the EMP, Reverse EMP, ED, Downstream ED (or 
lower glycolytic), and PP pathways during the uptake of glucose by B. megaterium. Reactions 
which are reported to occur but have not been experimentally verified are shown in red. 
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Figure 2. A simplified model network of the TCA cycle and gluconeogenic pathway in B. 
megaterium.  
 
Another possible metabolic pathway for initial glucose catabolism is the Entner-
Doudoroff (ED) pathway, which has not been considered in previous metabolic studies of 
Bacillus species (Tannlet er al., 2008; Furch et al., 2007a; Furch et al., 2007b). The ED pathway 
involves first the conversion of G6P to 6-PG, followed by the cleavage of 6-PG to form GAP and 
PYR (Sasnow et al., 2016) (Fig. 1). Tannler et al. (2008) reported that several strains of related 
Bacillus species, including B. subtilis, B. licheniformis, B. pumilus, and B. amyloliquefaciens, 
lack the genes encoding the ED pathway. However, B. megaterium QM B1551 is reported to 
possess the genes that encode ED pathway-associated enzymes (Kanehisa and Goto, 2000; 
Kanehisa et al., 2017). Metabolic flux networks constructed for Bacillus species, including B. 
megaterium, only show a uni-directional flow through the glycolysis pathway (Sauer et a., 1997; 
Dauner et al., 2001a; Furch et al., 2007a; Furch et al., 2007b; Tannler et al., 2008). However, B. 
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megaterium QM B1551 has been reported to have the enzymes necessary to perform 
gluconeogenesis and the reverse EMP pathway (Kanehisa and Goto, 2000; Kanehisa et al., 
2017), which have been previously unexplored for Bacillus species (Sauer et a., 1997; Dauner et 
al., 2001a; Furch et al., 2007a; Furch et al., 2007b; Tannler et al., 2008). Since B. megaterium is 
heavily integrated in the economy of industrial bioproducts, it is of great importance to 
understand how efficiently certain pathways are operating within the bacterium under certain 
growth conditions. 
Before glucose has the chance to be catabolized through the EMP or ED pathways, it can 
be converted to gluconate (Fig. 1). Overwhelmingly, gluconate has not been considered as a 
viable node in metabolic networks of Bacillus species (Sauer et al., 1997; Dauner et al., 2001a; 
Furch et al., 2007a; Furch et al., 2007b; Tannler et al., 2008; Korneli et al., 2012) (Fig. 1). Other 
species of bacteria will have a flux towards gluconate as an overflow mechanism when the cell 
encounters more carbon than it can use under certain conditions (Sasnow et al., 2016). Gluconate 
is a common product secreted by other bacterial species in the rhizosphere (Werra et al., 2009), 
and thus a ubiquitous soil bacterium like B. megaterium QM B1551 would be likely to encounter 
it in its native environment. It is therefore of interest to examine if B. megaterium QM B1551 
can process gluconate from the environment. 
There are several shortcomings to the previous MFA studies on Bacillus species (Sauer et 
al., 1997; Dauner et al., 2001a; Furch et al., 2007a; Furch et al., 2007b; Tannler et al., 2008; 
Korneli et a., 2012). These studies primarily considered glucose alone as the sole sugar carbon-
source for their models, and have not investigated mixed carbon substrates. Their models thus 
cannot predict what would happen when a B. megaterium cell in the rhizosphere encountered a 
mixture of sugars, or even simply a pentose sugar. Metabolic considerations regarding the 
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variety of carbon-sources that B. megaterium encounters in its nutritional environment, either in 
soil environments or in large-scale reactors, are essential for the generation and optimization of 
more realistic and predictive metabolic flux networks. In addition, all of these studies have used 
fractionally 
13
C-labeled amino acid quantification to constrain the flux network (Sauer et al., 
1997; Dauner et al., 2001a; Furch et al., 2007a; Furch et al., 2007b; Tannler et al., 2008; Korneli 
et a., 2012). This method relies on the bacterium producing free amino acids from specific 
metabolic nodes while the cell is growing on partially or fully isotopically-labeled substrates, 
typically 
13
C (Furch et al., 2007a; Furch et al., 2007b). The fraction of 
13
C-labeled amino acids is 
detected via gas chromatography coupled with mass-spectrometry (MS), and can then be used to 
calculate the fraction of 
13
C-labeled metabolites from which the acids were immediately derived 
(Furch et al., 2007a; Furch et al., 2007b). This method is insensitive to those amino acids which 
are hydrolytically unstable and relies on indirect observations to quantify intracellular 
metabolites. By contrast, the methodology employed by Aristilde et al. (2015) uses a 
metabolomics approach, which uses LC-MS technology to directly detect and quantify individual 
intracellular metabolites. This improves the overall resolution of both the metabolic network 
structure and the flux analysis, and is utilized in the present study. 
The Bacillus megaterium strain QM B1551 is one of the best-studied Gram-positive 
bacteria; the whole genome is sequenced and reports have indicated its potential for genetic 
recombination (Vary et al., 2007; Eppinger et al., 2011; Marchland et al, 2016). To address the 
lack of investigative research on the industrial workhorse and ubiquitous soil bacterium B. 
megaterium QM B1551, this study characterized the bacterium’s growth phenotype in the 
presence of glucose alone, fructose alone, xylose alone, and several mixtures of sugars and 
metabolite substrates. The implementation of isotopic labeling schemes allowed for individual 
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carbon atoms to be tracked through the metabolic network, and thus allowed for the verification 
and reassessment of the metabolic pathways available in B. megaterium QM B1551. In addition, 
the experimental labeling data provided constraints for the MFA analysis. A system of fluxes 
was generated through the MFA for growth on glucose, which was compared to the flux values 
reported in literature (Furch et al., 2007a). This will provide important information regarding the 
optimization of growth of this bacterium both in its natural habitat and in industrial applications. 
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METHODS 
I. Culturing conditions 
 Bacillus megaterium QM B1551 cells were obtained from the Bacillus Genetic Stock 
Center (Columbus, OH) on solid medium. Single colonies were re-suspended in 7 mL of 
Lysogeny Broth (LB) media, grown until late exponential phase, and plated on solid agar LB 
media. All plates were stored at 4°C until use. For carbon source-specific growth, liquid cultures 
were maintained in 20-mL glass test tubes or in 125-mL glass baffled flasks; these cultures were 
kept in an incubator shaker (New Brunswick Scientific, Edison, NJ) at 30°C and shaken at 220 
rpm (Sasnow et al., 2016). Tubes and flasks were covered with sponge caps to protect the 
cultures from contamination while allowing gas exchange. The bacterial cells were grown at pH 
7.0, in filter-sterilized (0.22 µm nylon; Waters Corporation, MA) minimal media, which 
contained the following in Milli-Q water: 18.7 mM NH4Cl, 0.81 mM MgSO4, 0.034 mM 
CaCl2•2H2O, 89.4 mM K2HPO4, 56.4 mM NaH2PO4•H2O, 8.6 mM NaCl, and trace metals. The 
trace metal concentrations were as follows: 30 µM FeSO4•7H2O , 1.9 µM H3BO3, 0.86 µM 
CuSO4•5H2O, 7.7 µM ZnSO4•7H2O, 0.75 µM MnSO4•H2O, 0.26 µM NiCl2•6H2O, 0.31 µM 
Na2MoO4•2H2O. The carbon-source for each experiment (330 mM C) was added to the minimal 
media as follows: only glucose (Gluc), only fructose (Fruc), only xylose (Xyl), 1:1:1 
Gluc:Fruc:Xyl, 1:1 Gluc:Glutamate, or 1:1 Gluc:Gluconate.  
 
II. Monitoring growth 
Cell growth was monitored via optical density (OD600) using an Agilent Cary UV-visible 
spectrophotometer (Santa Clara, CA). Single colonies of B. megaterium were first grown to late 
exponential phase in test tubes of LB media before being transferred to test tubes containing 
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minimal media. Once the cells had again reached late exponential phase, an aliquot from these 
test tubes was transferred to fresh minimal media in baffled flasks. The OD600 of a culture 
immediately following transfer was between 0.05 and 0.07. Two transfers as described above 
were performed for all experiments to ensure that the cells were well acclimated to their growing 
conditions prior to experimental sampling. To determine the cell dry weight in grams (gCDW), 1.5 
mL of culture was sampled after each OD600 reading and spun down at 9,391 g for 5 minutes at 
4°C (Centrifuge 5424 R, Eppendorf, Hauppauge, NY). The retentate was then stored at -20°C 
until it could be dried using a Labconco freeze-dryer (Kansas City, MO). The gCDW conversion 
factors for each carbon-source condition were found to be (in gCDW L
-1
 OD600
-1
): 0.61 ± 0.08 for 
Gluc; 0.69 ± 0.09 for Fruc; 0.42 ± 0.07 for Xyl; 0.43 ± 0.10 for Gluc:Fruc:Xyl. 
 
III. Measurement of sugar uptake 
 To quantify the rate of consumption of carbon from the media in the Gluc, Fruc, Xyl, and 
Gluc:Fruc:Xyl conditions, 0.7 mL samples were harvested from three biological replicates 
throughout cell growth. These samples were centrifuged for 30 minutes at 15,871 g and 4°C in 
filter microcentrifuge tubes (0.22 µm pore size nylon). The filtered supernatants were frozen at   
-20°C until further processing. In preparation for analysis via nuclear magnetic resonance 
(NMR), 200 µL of filtered sample were mixed with 60 µL of 100% D2O, 50 µL of 6 mM 2,2-
dimethyl-2-silapentane-5-sulfonate (DSS) as an internal standard, 240 µL of 100 mM sodium 
bicarbonate as a pH control, and 50 µL of 10 mM sodium-azide as an antimicrobial agent. 
Samples were stored at 4°C until analysis (Kukurugya, 2017). The NMR samples were analyzed 
by proton NMR using a Varian Unity INOVA 600-MHz NMR spectrometer at 25°C, with a 
relaxation delay of 5 seconds, recording of 16 scans per sample, and receiver gain of 32 dB 
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(Aristilde et al., 2015; Kukurugya, 2017). As done previously, the depletion of sugars in the 
extracellular medium was taken to approximate sugar uptake (Aristilde et al., 2015). Carbon 
consumption rates of exponentially-growing cells (in mmol gCDW
-1
 h
-1
) were determined via 
regression analysis. For the sugar substrate mixture, the consumption rates of the individual 
sugars were calculated by normalizing the NMR signal intensity of the stock solution to the 
NMR signal intensity of several concentration standards of the mixture of sugars. 
 
IV. LC-MS analysis 
As described in introduction, isotopic-labeling samples and metabolic excretion samples 
were generated to create constraining parameters for MFA. Metabolite standards of 1000 nM, 
500 nM, 250 nM, 100 nM, 50 nM, and 10 nM concentrations were run in parallel with the 
excretion sample. These samples and standards were analyzed by reversed-phase ion-pairing LC 
via ultra-high performance LC (Thermo Scientific DionexUltiMate 3000) coupled to high-
resolution/accurate-mass mass spectrometer (Thermo Scientific Q Exactive quadrupole-Orbitrap 
hybrid MS) with electrospray ionization (ESI), run in full scan negative mode (Kukurugya, 2017; 
Sasnow, 2016). Mobile phases for the LC-MS consisted of solvents A and B; Solvent A was 
composed of 97:3 (v/v) LC-MS grade H2O: methanol with 15 mM acetic acid and 10 mM 
tributylamine; Solvent B was pure methanol (Kukurugya, 2017). The flow rate was 180 µL min
-1
 
for the duration of a given sample’s analysis, with a solvent A gradient of 0 min, 100%; 2.5 min, 
100%; 5 min, 80%; 7.5 min, 80%; 10 min, 45%; 12 min, 45%; 14 min, 5%; 17 min, 5%; 18 min, 
0%; 25 min, 0% (Kukurugya, 2017; Sasnow, 2016). Injection volume for each sample was 10 
µL, with a consistent column temperature of 25°C. An Acquity UPLC Waters 1.7 µm particle 
size column was used for all samples and experiments (Milford, MA). The following metabolites 
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were tracked for the MFA: gluconate, 6-phospho-gluconate (6-PG), G6P, F6P, FBP, PYR, 
xylulose-5-phosphate (Xu5P), ribose-5-phosphate (R5P), DHAP, phosphoenolpyruvate (PEP), 
citrate, α-ketogluterate, succinate, fumarate, malate, aspartate, and sedoheptulose-1/7-
bisphosphate (S7P). Aspartate was taken as a proxy for oxaloacetate (OAA), as was done 
previously (Amador-Noguez et al., 2010; Kukurugya, 2017; Sasnow et al., 2016). 
 
V. Metabolite excretion 
 To determine the rate of excretion of metabolites, 50 µL of filtered supernatant was taken 
from the Gluc and Gluc:Fruc:Xyl consumption samples during growth. These samples were then 
diluted 1:20 with LC-MS grade water (Fisher Scientific, Pittsburgh, PA) during early exponential 
phase, or 1:200 during late exponential and stationary phases. Higher dilutions were used at 
higher OD600 readings due to very high concentrations of metabolites in the extracellular media. 
The samples were stored at 4°C for no more than 5 hours prior to processing in the LC-MS.  
Excretion rates (µmol gCDW
-1
 h
-1
) were calculated via regression analysis.  
 
VI. Long-term isotopic labeling 
The intracellular metabolite pool levels at pseudo-steady state were observed for cells in 
exponential growth (Sasnow, 2016). Long-term isotopic enrichment of the metabolites was 
achieved with [U-
13
C6]-Gluc, [1,2-
13
C6]-Gluc, 1:1 [U-
13
C6]-Gluc: unlabeled glutamate, 1:1:1 
[1,2,3-
13
C6]-Gluc: [1,6-
13
C6]-Fruc: unlabeled Xyl, and 1:1 [U-
13
C6]-Gluc: unlabeled gluconate. 
All labeled sugars were purchased from Cambridge Isotopes (Tewskbury, MA) or Omicron 
Biochemicals (South Bend, IN). Batch cultures (two biological replicates) were grown twice in 
labeled minimal media until the OD600 reached 1 and 2. At each OD600, aliquots (3 mL) of 
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culture were filtered through 0.22 µm pore nylon filter disks in the presence of both a vacuum 
and a flame from a Bunsen burner to prevent contamination. The cells remaining on the filter 
disk were immediately quenched in 2 mL of 4°C 2:2:1 methanol:acetonitrile:water. The lysed 
cells were scraped from the filter disk into the quenching solution, which was then centrifuged 
for 5 minutes at 4°C and 9,391 g. Two 100 µL aliquots of the resulting supernatant were dried 
down under N2 gas (50 minutes). The dried metabolites were then re-suspended in 100 µL LC-
MS water, and processed via LC-MS as described in section IV. The isotopic labeling patterns 
were analyzed with the MAVEN (Metabolomic Analysis and Visualization Engine) software 
suite (Melamud et al., 2010; Clasquin et al., 2012). Natural abundance of 
13
C was corrected for 
using a correctional MATLAB code developed at Princeton University. The relative abundances 
of individual metabolites were normalized and compared across carbon-source conditions. 
The MAVEN software determined the relative proportions of the isotopes of each 
metabolite according to the signal intensity of the metabolite in the sample (Clasquin et al., 
2012); to ascertain that the signals detected by MAVEN were legitimate representations of the 
metabolite concentrations, a series of metabolite calibrations were run using carbon source 
standards at fixed concentrations, and the total size of several metabolite pools were calculated in 
tractable units of uM/gCDW. 
The isotopic labeling of the environmental CO2 was monitored by tracking the long-term 
isotopic enrichment profiles of ornithine and citrulline. Citrulline, a six-carbon metabolite, was 
formed when CO2 was captured as a carbamoyl phosphate and incorporated with ornithine, a 
five-carbon metabolite (Legrain et al, 1977). Other Bacillus species have been reported to 
express ornithine carbamoyltransferase, the enzyme responsible for catalyzing this reaction, and 
thus it was assumed that B. megaterium QM B1551 also possessed a copy of the gene encoding 
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this enzyme (Issaly et. al., 1974). Since fully 
13
C-labeled citrulline could only be derived from 
fully 
13
C-labeled ornithine combining with 
13
C-labeled CO2, the fraction of 
13
C-labeled CO2 was 
calculated by dividing the fraction of sextuply 
13
C-labeled citrulline by the fraction of quintuply 
13
C-labeled ornithine. 
 
VII. Kinetic isotopic labeling  
In vivo incorporation of carbon into B. megaterium was determined via kinetic flux 
experiments. Batch cultures (three biological replicates) were grown twice in unlabeled minimal 
media with either Gluc or Gluc:Glutamate until early exponential phase, corresponding to OD600 
0.4 to 0.6. Aliquots (3 mL) of the cultures were then filtered through 0.22 µm pore nylon filter 
disks in the presence of both a vacuum and a flame from a Bunsen burner. A total of 18 cell-
laden filter disks were generated. Each disk was then placed cell-side up on a small agar plate 
containing unlabeled carbon in minimal media and allowed to grow to exponential phase, 
corresponding to OD600 0.5 (Sasnow, 2016). The cells experienced multiple doubling times to 
become fully acclimated to the new growing conditions prior to the kinetic incorporation of 
isotopes. The disks were transferred to agar plates containing labeled carbon in minimal media 
and allowed to grow on the labeled media for fixed time intervals. The labeled carbon used was 
either [U-
13
C6]-Gluc or 1:1 [U-
13
C6]-Gluc:unlabeled glutamate. After a set period of time 
following the isotopic switch (0 sec, 20 sec, 1 min, 4 min, 12 min, 30 min), the filter disk was 
removed from the labeled plate and metabolism was immediately quenched by flipping the disk 
cell-side down into 2 mL of 4°C 2:2:1 methanol:acetonitrile:water. The lysed cells were scraped 
from the filter disk into the quenching solution, which was then centrifuged for 5 minutes at 4°C 
and 9,391 g. Two 100 µL aliquots of the supernatant were dried down under N2 gas (50 
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minutes). The dried metabolites were then re-suspended in 100 µL of LC-MS water and 
processed as described in section IV. The isotopic labeling patterns were analyzed with the 
MAVEN software suite, as described in section VI, and corrected for the natural abundance of 
13
C (Melamud et al., 2010; Clasquin et al., 2012). 
  
VIII. Metabolic Flux Analysis 
To predict the relative flux of carbon through a B. megaterium QM B1551 cell, a model was 
constructed using metabolomics flux analysis (MFA). This analysis estimated the relative flux of 
metabolites, normalized to the uptake of carbon substrate, between different nodes in a metabolic 
network. Determining which reaction pathways were utilized by B. megaterium QM B1551 
required a priori knowledge of the metabolic network within the strain. Metabolites of interest 
were considered as nodes in the network. The reactions between them were used to construct 
ordinary differential equations to solve for the fluxes, provided some constraining parameters 
and initial conditions.  The consumption rates, excretion rates, LC-MS isotopic labeling data, and 
biomass composition of B. megaterium for the Gluc alone condition were used as system 
constraints on the MFA model.  
The stoichiometric biomass composition of B. megaterium was not available, so the 
composition of B. subtilis was used instead (Dauner et al., 2001b). Briefly, the metabolic 
requirements for cell growth were calculated for each substrate condition, and used as effluxes in 
the metabolic network. Any reaction which involved a carboxylation or decarboxylation was 
treated as irreversible. All reversible reactions within the network were reported as a net flux 
between the nodes. The network was limited to a set number of nodes in the glycolytic pathway, 
PP pathway, and TCA cycle (Fig. 37). The model was initialized using a number of free fluxes, 
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which were chosen to 1) force the system to have a 100% influx of Gluc and 2) ensure that the 
resulting fluxes were physically realistic. The latter point was accomplished by setting the free 
fluxes to values that were similar or identical to previously determined fluxes in B. megaterium 
(Furch et al., 2007a). 
The software suite 13CFLUX2 was run to generate metabolic reaction rates between a 
supplied set of metabolite network nodes (Weitzel et al., 2012). The model assumed that only 
succinate, gluconate, fumarate, aspartate, citrate, αKG, glutamate, and PYR would be secreted, 
and included biomass effluxes from the G6P, R5P, E4P, 3PG, PEP, PYR, Ac-CoA, OAA, αKG, 
and DHAP nodes. The program generated an initial set of flux values which were then optimized 
according to the supplied constraints. The program used each iteration of generated flux values 
to compute the likely labeling patterns for each metabolite node of interest in the network; the 
program then calculated the error (residuals) between the experimental LC-MS long-term isotope 
labeling data and the generated patterns to ascertain the quality of the fit. The user determined 
the duration of the optimization process (Sasnow, 2016).  
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RESULTS AND DISCUSSION 
I. Growth phenotype and sugar consumption 
To begin assembling the necessary constraints for the MFA in Bacillus megaterium QM 
B1551, the growth rates and substrate consumption rates during growth on the various carbon 
sources were investigated. The growth rate on each carbon-source was found to be (in h
-1
): 0.71 
± 0.04 for Gluc, 0.62 ± 0.04 for Fruc, 0.38 ± 0.02 for Xyl, 0.57 ± 0.07 for Gluc:Fruc:Xyl, 0.73 ± 
0.04 for Gluc:Glutamate, and 0.75 ± 0.05 for Gluc:Gluconate (Fig. 3). The growth curves for all 
carbon-conditions are shown in Figure S1 in the Appendix.  
 
Figure 3. The specific growth rate (h
-1
) of B. megaterium QM B1551 grown on glucose (dark 
blue), fructose (red), xylose (tan), Gluc:Fruc:Xyl (purple), Gluc:Glutamate (yellow), or 
Gluc:Gluconate (light blue). The growth rates were determined using just the exponential 
growth. Two-tailed unpaired t-test analysis was conducted to compare the growth rates relative 
to the Gluc condition with n=3. * indicates P < 0.05, and ** indicates P < 0.01 
 
 The sugar consumption rates of Gluc, Fruc, and Xyl as the sole substrates (mmol sugar 
gCDW
-1
 h
-1
 ) were found to be 5.30 ± 1.61, 2.88 ± 2.30, and 0.41 ± 0.06 respectively. The sugar 
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consumption rates of Gluc, Fruc, and Xyl in the Gluc:Fruc:Xyl mixture (mmol sugar gCDW
-1
 h
-1
) 
were found to be 2.8 ± 0.06, 1.3 ± 0.05, and negligible, respectively.  
 
II. Metabolic Network Structure 
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Figure 4. The theoretical isotopic distribution of the metabolic network of B. megaterium 
growing on [U-
13
C]-Gluc. The pathways shown in red (gluconate incorporation and ED 
pathway) have been proposed, but are not verified in this experiment. The purple carbons are 
incorporated CO2. The green background shows the fate of the Ac-CoA atoms in the TCA cycle. 
The yellow background shows the carbons that are canonically cleaved in the citrate 
decarboxylation reaction; the blue background shows the carbons that are canonically cleaved in 
the αKG decarboxylation reaction. 
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To determine that Bacillus megaterium QM B1551 had reached metabolic pseudo-steady 
state, we obtained long-term isotopic enrichment of its intracellular metabolites using [U-
13
C]-
Gluc at two sampling points during the exponential growth phase (OD600 1 and 2). In a pseudo-
steady state condition, complete isotopic enrichment across all metabolites at both sampling 
times would indicate that the cells had fully incorporated the 
13
C-labeled Gluc, and that a flux-
balance was achieved at each metabolic network node (Fig. 4). Indeed, we found that enrichment 
with [U-
13
C]-Gluc resulted in fully 
13
C-labeled metabolites in the EMP and PP pathways at both 
sampling times (Fig. 5, 6). The complete 
13
C labeling of metabolites continued through pyruvate 
(PYR), the three-carbon metabolite downstream of glycolysis and directly upstream of the TCA 
cycle (Fig. 6). These data were thus consistent with pseudo-steady state metabolic conditions.  
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Figure 5. The isotopic labeling fractions, with standard deviations, for five metabolites in the 
glycolytic EMP pathway when grown on [U-
13
C]-Gluc. The two columns for each metabolite 
represent the average isotopic labeling distribution at OD 1 (left) and OD 2 (right). 
Abbreviations used: G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; 6PG, 6-phospho-
gluconate; FBP, fructose-bis-phosphate 
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Figure 6. The isotopic labeling fractions, with standard deviations, for three PP pathway 
metabolites (top row), and for three lower glycolytic 3C metabolites (bottom row) when grown 
on [U-
13
C]-Gluc. The two columns for each metabolite represent the average isotopic labeling 
distribution at OD 1 (left) and OD 2 (right). Abbreviations used: R5P, ribose-5-phosphate; Xu5P, 
xyulose-5-phosphate; S7P, sedoheptulose-7-phosphate; DHAP, dihydroxy-acetone-phosphate; 
PEP, phosphoenolpyruvate 
 
The TCA cycle metabolites did not reflect fully 
13
C-labeled fractions due to the 
incorporation of unlabeled CO2 from the environment (Fig. 7, 8). Citrate, a six-carbon 
metabolite, was approximately 80% sextuply 
13
C-labeled and 20% quintuply 
13
C-labeled (Fig. 8). 
It follows that the average fraction of nonlabeled CO2 should be about 20% (Fig. 8). However, 
the fraction of non
13
C-labeled CO2 was only 8%, which was too low to account for all of the 
13
C-
labeled citrate (Fig. 7, 8). One possible explanation for this discrepancy was that the flux into the 
TCA cycle may have be limited, and that the TCA cycle metabolites had not yet reached pseudo-
steady state by OD600 1 or 2. This hypothesis was supported by the observation that the other 
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metabolites in the TCA cycle also displayed differences in their isotopic profiles at both OD600 
readings (Fig. 8).   
 
Figure 7. The fraction of unlabeled CO2 (blue) and fully 
13
C-labeled CO2 (red) dissolved in the 
growth medium for each of the experimental conditions tested. These values represent an 
average of CO2 measurements from OD600 2. 
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Figure 8. The isotopic labeling fractions, with standard deviations, for five metabolites in the 
TCA cycle when grown on [U-
13
C]-Gluc. The two columns for each metabolite represent the 
average isotopic labeling distribution at OD 1 (left) and OD 2 (right). The abbreviation αKG 
stands for α-ketoglutarate. 
  
Moving through the TCA cycle, citrate lost its first carbon position to become αKG, a 
five-carbon metabolite which was 90-95% quintuply 
13
C-labeled and 10-5% quadruply 
13
C-
labeled (Fig. 8). Compared to the citrate labeling, which was 80% sextuply 
13
C-labeled and 20% 
quintuply 
13
C-labeled, the αKG labeling implied that the carbon lost as CO2 from citrate was 
primarily nonlabeled (Fig. 8). This hypothesis holds interesting implications for the 
stereochemistry of citrate, as the canonical cleavage of citrate to αKG involves the loss of the 
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first carbon of citrate, which is 
13
C-labeled in this scheme (Fig. 4). This implies that a different 
carbon position of citrate may have been cleaved during the decarboxylation reaction to αKG. In 
this 
13
C-labeling scheme, the only nonlabeled carbon in citrate was derived from the addition of 
unlabeled CO2 to PYR to form OAA, which became the fourth carbon position of citrate (Fig. 4). 
For this carbon to be cleaved in the decarboxylation to αKG, either B. megaterium possessed a 
unique enzyme which cleaved citrate at the fourth carbon position, or the orientation of the OAA 
molecule was flipped prior to its incorporation into citrate such that the nonlabeled carbon 
occupied the first carbon position of citrate. 
Subsequent decarboxylation of αKG resulted in CO2 and succinate, a four-carbon 
metabolite (Fig. 1). At pseudo-steady state, succinate was between 84-92% quadruply 
13
C-
labeled, which closely matched quintuply 
13
C-labeled αKG (Fig. 8). If succinate was derived 
entirely from αKG, it would be expected that the remaining 8-16% of the metabolite pool would 
be triply 
13
C-labeled; however, the remaining succinate isotope was nonlabeled (Fig. 8). This 
means that even when grown twice on [U-
13
C]-Gluc, B. megaterium QM B1551 was somehow 
able to retain unlabeled carbon atoms in its succinate metabolite pool, or was deriving them from 
some other carbon source than the sugar substrate. Since the growth medium contained no other 
carbon source besides fully 
13
C-labeled Gluc, this latter theory is unlikely. Fumarate was almost 
entirely nonlabeled at both OD600 readings, indicating that the 
13
C-labeled carbon derived from 
the Gluc substrate was not reaching the fumarate metabolite pool (Fig. 8). 
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Figure 9. The total size of several metabolite pools, summed over all isotopic fractions for a 
given metabolite, for OD600 1 and 2.  
 
Fumarate could have been primarily nonlabeled for two reasons; either fumarate was not 
synthesized, or there was an error in the MAVEN isotopic fractionation. The low level of 
fumarate in the samples, in addition to the low quality of the fumarate peaks in MAVEN (data 
not shown), support the theory that there was an error in the MAVEN isotopic algorithm (Fig. 9). 
However, succinate had a reasonable quantifiable level of expression, and therefore should not 
have experienced errors in MAVEN. This implies that the increase in non 
13
C-labeling in 
succinate is legitimate. This in turn implies that the flux through the TCA cycle is severely 
constricted, and that pseudo-steady state was likely not achieved for these metabolites by OD600 1 
and 2 (Fig. 9). 
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As mentioned previously, PYR is carboxylated to form OAA. In this experiment, the 
isotopic labeling of OAA, as determined from aspartate, closely resembled that of PYR, with the 
addition of some unlabeled CO2 (Fig. 6, 8). Specifically, OAA was approximately 85% 
quadruply 
13
C-labeled and 15% triply 
13
C-labeled (Fig. 8). These isotopic proportions were very 
similar to those of citrate, which supports the generally accepted model of the TCA cycle, 
wherein OAA combines with Ac-CoA to form citrate in a non-reversible reaction. Provided that 
Ac-CoA is derived from the triply 
13
C-labeled PYR, adding doubly 
13
C-labeled carbon to the 
isotopic fractions of OAA could yield the measured isotopic fractions of citrate (Fig. 8). It should 
be noted that unlike succinate, OAA does not have a significant fraction of nonlabeled moieties 
(Fig. 8). This observation again leads us to suspect that B. megaterium QM B1551 is not 
producing fumarate in significant quantities. Since all bacterial cultures grew to OD600 readings 
of 10 or higher, the metabolite quantification implied that a complete TCA cycle is not necessary 
for sufficient cell growth (Fig 9, S1).  
We verified the proposed metabolic network structure of B. megaterium QM B1551 
using [1,2-
13
C]-Gluc. This isotope of Gluc was chosen because of the unique 
13
C-labeling 
patterns that would be generated throughout the metabolic network. Upon entering the cell, 
doubly 
13
C-labeled Gluc is converted to doubly 
13
C-labeled G6P, which in turn becomes doubly 
13
C-labeled 6-PG (Fig. 10). The first position of 6-PG is cleaved through the oxidative PP 
pathway to yield singly 
13
C-labeled pentose-phosphate metabolites, R5P and Xu5P (Fig. 10). 
Alternatively, G6P can follow the EMP pathway, eventually producing nonlabeled and doubly 
13
C-labeled triose-phosphates (Fig. 10). These triose-phosphates combined with doubly 
13
C-
labeled F6P generate primarily doubly 
13
C-labeled pentose-phosphates (Fig. 10). Thus, we 
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expected to use the pentose metabolites to determine the bacterium’s preference for oxidative vs 
non-oxidative PP pathway. 
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Figure 10. The theoretical isotopic distribution of the metabolic network of B. megaterium 
growing on [1,2-
13
C]-Gluc. The pathways shown in red (gluconate incorporation and ED 
pathway) have been proposed, but are not verified in this experiment. The blue filled carbons in 
FBP indicate isotopes derived from gluconeogenesis. The purple carbons are incorporated CO2. 
The purple carbons show two different CO2 incorporation schemes, either addition to the front of 
PYR or addition to the end of PYR. The green background shows the fate of the Ac-CoA atoms 
in the TCA cycle. The yellow background shows the carbons that are canonically cleaved in 
decarboxylation of citrate to αKG. The blue background shows the carbons that are canonically 
cleaved in decarboxylation of αKG to succinate. The red background reiterates the position of 
the added CO2 when OAA is flipped prior to its acetylation. 
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In the upper glycolytic pathway, G6P, gluconate, F6P, and 6-PG were all primarily 
doubly 
13
C-labeled, as would be expected from growing on doubly 
13
C-labeled Gluc (Fig. 10, 
11). FBP was largely doubly 
13
C-labeled, but also had 15% quadruply 
13
C-labeled, 10% 
nonlabeled, and fractions of singly 
13
C-labeled and triply 
13
C-labeled moieties (Fig. 11). 
Downstream from FBP, PYR was 50% nonlabeled and slightly over 40% doubly 
13
C-labeled 
(Fig. 12); this would be an expected labeling pattern if [1,2-
13
C]-6-PG or [1,2-
13
C]-FBP split to 
make nonlabeled or doubly 
13
C-labeled DHAP and PYR (Fig. 10). It is possible, then, that the 
quadruply 
13
C-labeled and nonlabeled FBP moieties were derived from gluconeogenesis, which 
has not yet been reported for this strain (Fig. 1, 10, 11, 12).  
32 
 
 
Figure 11. The isotopic labeling fractions, with standard deviations, for five metabolites in the 
glycolytic EMP pathway when grown on [1,2-
13
C]-Gluc. The two columns for each metabolite 
represent the average isotopic labeling distribution at OD 1 (left) and OD 2 (right). 
Abbreviations used: G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; 6PG, 6-phospho-
gluconate; FBP, fructose-bis-phosphate 
 
The roughly 5% of PYR, DHAP, and PEP that were singly 
13
C-labeled were most likely 
derived from the PP pathway (Fig. 10, 12, 13). The pentose-phosphate metabolites R5P and 
Xu5P were both approximately 75% singly 
13
C-labeled, indicating that these metabolites were 
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derived primarily through the oxidative PP pathway (Fig. 10, 13). In this scheme, the oxidative 
PP pathway involved doubly 
13
C-labeled 6-PG losing the 
13
C-labeled carbon in its first position 
to become a singly 
13
C-labeled pentose sugar (Fig. 10). If the ribose sugars were populated via 
the nonoxidative PP pathway, one would expect to see a much higher isotopic fraction of doubly 
13
C-labeled pentose sugars; the non-oxidative PP pathway would use a transketolase reaction to 
transfer the two labeled carbons in the first and second positions of doubly 
13
C-labeled F6P onto 
nonlabeled GAP to form doubly 
13
C-labeled Xu5P (Fig. 10, 11, 13). As described in the 
Introduction, the previously reported fluxes for the oxidative PP pathway in B. megaterium 
strains were inconsistent, and therefore this finding was significant (Sauer et al., 1997; Dauner et 
al., 2001; Furch et al., 2007a; Furch et al., 2007b; Tannlet et al., 2008). 
 
Figure 12. The isotopic labeling fractions, with standard deviations, for three lower glycolytic 3C 
metabolites when grown on [1,2-
13
C]-Gluc. The two columns for each metabolite represent the 
average isotopic labeling distribution at OD 1 (left) and OD 2 (right). Abbreviations used: 
DHAP, dihydroxy-acetone-phosphate; PEP, phosphoenolpyruvate 
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Figure 13. The isotopic labeling fractions, with standard deviations, for three PP pathway 
metabolites when grown on [1,2-
13
C]-Gluc. The two columns for each metabolite represent the 
average isotopic labeling distribution at OD 1 (left) and OD 2 (right). Abbreviations used: R5P, 
ribose-5-phosphate; Xu5P, xyulose-5-phosphate; S7P, sedoheptulose-7-phosphate 
 
 Moving into the TCA cycle, PYR generated primarily nonlabeled and doubly 
13
C-labeled 
Ac-CoA, which combined with OAA to form citrate (Fig. 10, 14). Citrate had a fairly broad 
distribution of isotopic fractions, including 23% nonlabeled, 13% singly 
13
C-labeled, 33% 
doubly 
13
C-labeled, 14% triply 
13
C-labeled, 13% quadruply 
13
C-labeled, and 3% quintuply 
13
C-
labeled moieties (Fig. 14). The isotopic proportions of αKG were nearly identical to those of 
citrate (Fig. 14). These findings directly contrasted those of Sasnow (2016), who found that in 
the metabolic network of Pseudomonas putida grown on [1,2-
13
C]-Gluc, the isotopic fractions of 
αKG  matched those of citrate, implying that a labeled carbon was lost in the decarboxylation. 
The results for B. megaterium QM B1551 suggested that the carbon lost in this reaction was 
nonlabeled, which could indicate a unique stereochemistry for citrate synthesis and cleavage in 
this organism (Fig. 14). This finding also supported the observation from the [U-
13
C]-Gluc 
condition, in which an unlabeled carbon was suspected to be lost during the decarboxylation 
reaction from citrate to αKG (Fig. 4). 
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Figure 14. The isotopic labeling fractions, with standard deviations, for six metabolites in the 
TCA cycle when grown on [1,2-
13
C]-Gluc. The two columns for each metabolite represent the 
average isotopic labeling distribution at OD 1 (left) and OD 2 (right). The abbreviation αKG 
stands for α-ketoglutarate. 
 
 There are a number of alternative chemical reactions which could explain the identical 
isotopic profiles in citrate and αKG (Fig. 14). For the labeling profiles to remain the same from 
citrate to αKG after decarboxylation, the carbon cleaved from citrate must be a nonlabeled 
terminal carbon in the citrate structure accessible to an enzyme. One hypothesis was that there 
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was an alternate addition of CO2 to PYR to form a stereoisomer of OAA (Fig. 10). It was 
previously reported that in the carboxylation reaction which combines CO2 and PYR to form 
OAA, the carbon from CO2 is added in front of the first carbon position in the PYR molecule 
(Sasnow et al., 2016) (Fig. 2). Once OAA combines with Ac-CoA, what had been the fourth 
carbon of OAA is cleaved in the decarboxylation from citrate to αKG (Fig. 2). If, however, the 
carbon from CO2 were added to the end of PYR to take the final position of OAA, that would 
leave a consistently nonlabeled carbon at the first position of OAA (Fig. 10). This would 
subsequently become the fourth carbon of citrate. If, however, OAA was flipped prior to its 
incorporation into citrate, the consistently nonlabeled carbon would occupy the first position of 
citrate, which could be cleaved to maintain an identical isotopic profile in αKG (Fig. 10). Other 
possibilities for alternative reactions include a different cleavage of PYR to form Ac-CoA, or an 
altered addition of Ac-CoA to OAA to form citrate. These hypotheses and others not listed here 
will require additional isotopic experiments to verify their validity 
Continuing on in the TCA cycle, succinate had a higher fraction of nonlabeled moieties 
(40-50%) than could have been derived solely from αKG (21% nonlabeled) (Fig. 14). This 
mirrored the increased proportion of nonlabeled succinate observed in the [U-
13
C]-Gluc 
condition (Fig. 8). Also as before, fumarate had a significant fraction of nonlabeled moieties, 
between 40 and 60% (Fig. 14). A similar metabolic quantification was employed for this 
condition and compared to the metabolite quantifications from the [U-
13
C]-Gluc condition (Fig. 
15). Based on the metabolite quantifications, the observed increased nonlabeled moieties in 
fumarate were assumed to be either software error or indicative of a low flux through the TCA 
cycle (Fig. 14, 15). 
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Figure 15. The quantifications of several metabolites averaged over OD600 readings 1 and 2 for 
both the [U-
13
C]-Gluc condition (Gluc) and the [1,2-
13
C]-Gluc condition (1,2 Gluc). 
 
OAA had an isotopic distribution of 39% nonlabeled, 17% singly 
13
C-labeled, 32% 
doubly 
13
C-labeled, 10% triply 
13
C-labeled, and 2% quadruply 
13
C-labeled moieties (Fig. 14). 
The isotopic distribution of aspartate was reminiscent of that of PYR, likely because the CO2 was 
largely nonlabeled (Fig. 7, 12, 14). This means that any OAA derived from the carboxylation of 
PYR and CO2 would have similar proportions of isotopes as PYR (Fig. 12, 14). The 10% of 
aspartate that was triply 
13
C-labeled was derived from a carboxylation combining 
13
C-labeled 
CO2 and doubly 
13
C-labeled PYR (Fig. 7, 12, 14).  
Once again, these findings are suggestive of a bifurcated TCA cycle. Both the metabolic 
labeling and the metabolite pools implied a bottleneck of fluxes from citrate to αKG, from αKG 
to succinate, and from OAA to fumarate (Fig. 14, 15).  
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In the above experiments, we obtained a small pool of fully 
13
C-labeled gluconate during 
growth on [U-
13
C]-Gluc and a small pool of doubly 
13
C-labeled gluconate during growth on [1,2-
13
C]-Gluc (Fig. 5, 9, 11, 15). Since these labeling patterns of gluconate could only be derived 
from the provided Gluc sources, these results indicate that gluconate could be involved in the 
initial Gluc metabolism. However, in previous MFA models of Bacillus species, the gluconate 
node was frequently omitted from the glycolytic pathway (Sauer et al., 1997; Dauner et al., 
2001a; Furch et al., 2007a; Furch et al., 2007b; Tannler et al., 2008; Korneli et al., 2012. To 
prove if B. megaterium QM B1551 could incorporate and utilize gluconate, cell cultures were fed 
a 50:50 mixture of [U-
13
C]-Gluc and unlabeled gluconate (Fig. 16). If gluconate could be 
incorporated into the metabolic network, nonlabeled moieties should be present in metabolites 
downstream from gluconate, such as 6-PG (Fig. 16). Metabolites that were not synthesized from 
gluconate should have full 
13
C-labeling patterns, derived from glucose (Fig. 16). 
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Figure 16. The theoretical isotopic distribution of the metabolic network of B. megaterium 
growing on [U-
13
C]-Gluc and unlabeled gluconate. The ED pathway was shown not to be present 
in this bacterium. The blue carbons in FBP indicate isotopes derived from gluconeogenesis. The 
purple carbons are incorporated CO2. The green background shows the fate of the Ac-CoA atoms 
in the TCA cycle. The yellow background shows the carbons that are canonically cleaved in 
decarboxylation from citrate to αKG. The blue background shows the carbons that are 
canonically cleaved in decarboxylation from αKG to succinate. The red background reiterates 
the position of the added CO2 when OAA is flipped prior to its acetylation. 
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Figure 17. The isotopic labeling fractions, with standard deviations, for five intracellular 
metabolites in the glycolytic EMP pathway when grown on [U-
13
C]-Gluc and nonlabeled 
gluconate. The two columns for each metabolite represent the average isotopic labeling 
distribution at OD 1 (left) and OD 2 (right). Abbreviations used: G6P, glucose-6-phosphate; F6P, 
fructose-6-phosphate; 6PG, 6-phospho-gluconate; FBP, fructose-bis-phosphate 
 
 As expected, G6P was almost entirely sextuply 
13
C-labeled, indicating that it was derived 
from glucose (Fig. 16, 17). The isotopic profile of gluconate, which was almost entirely 
nonlabeled, could not be distinguished between the extracellular and intracellular pools of 
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gluconate (Fig. 17). Thus, a more reliable indication of gluconate incorporation necessitated the 
monitoring of downstream metabolites such as 6-PG. We found that 6-PG was 18% and 36% 
nonlabeled at OD600 1 and 2, respectively (Fig. 17). This indicated that both G6P and gluconate 
contributed to the 6-PG metabolite pool, and that the flux from G6P to 6-PG was preferred to the 
flux from gluconate to 6-PG at earlier OD600 readings than at later OD600 readings (Fig. 17). The 
isotopic profiles of the metabolites of the PP pathway were also in agreement with gluconate 
assimilation downstream in the metabolic network (Fig. 16, 17, 18).  
 
Figure 18. The isotopic labeling fractions, with standard deviations, for three intracellular PP 
pathway metabolites when grown on [U-
13
C]-Gluc and nonlabeled gluconate. The two columns 
for each metabolite represent the average isotopic labeling distribution at OD 1 (left) and OD 2 
(right). Abbreviations used: R5P, ribose-5-phosphate; Xu5P, xyulose-5-phosphate; S7P, 
sedoheptulose-7-phosphate 
 
 
 Nonlabeled carbons in the oxidative PP pathway also generated nonlabeled and triply 
13
C-labeled 3-phosphoglycerate (3PG) (Fig. 16, 19). As a downstream metabolite of DHAP and 
GAP, 3PG was used as a proxy for GAP isotopic labeling. Specifically, 3PG was ~90% triply 
13
C-labeled, and ~6% nonlabeled (Fig. 19). The triply 
13
C-labeled 3PG moieties were derived 
from Gluc, and the slight decrease in triply 
13
C-labeled 3PG moieties with increasing OD600 
supported the aforementioned hypothesis that Gluc was the preferred substrate at early stages of 
exponential growth (Fig. 19). The low proportion of nonlabeled 3PG moieties indicated that 
carbons derived from gluconate were incorporated as far downstream as the lower glycolytic 
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pathway, but to a lesser extent than they were incorporated in the oxidative PP pathway (Fig. 16, 
19).  
 
Figure 19. The isotopic labeling fractions, with standard deviations, for three intracellular lower 
glycolytic 3C metabolites when grown on [U-
13
C]-Gluc and nonlabeled gluconate. The two 
columns for each metabolite represent the average isotopic labeling distribution at OD 1 (left) 
and OD 2 (right). Abbreviations used: 3PG, 3-phosphglycerate; PEP, phosphoenolpyruvate 
 
A series of reactions convert GAP to PEP to PYR, and while GAP and PEP both 
contained nonlabeled moieties, PYR was 99% triply 
13
C-labeled (Fig. 16, 19). This could suggest 
that Gluc is consumed sooner than gluconate and that the flux through the three-carbon 
metabolites is relatively low, that PYR was synthesized through an alternative pathway, or that 
the PYR metabolite was relatively low in concentration and could not be adequately isotopically 
fractionated.  
The MAVEN signal intensity of PYR was investigated to determine if the unexpected 
labeling pattern in PYR followed a similar error as the labeling patterns previously seen in 
fumarate. As before, the metabolite pools for this condition were quantified (Fig. 20). The 
MAVEN signal for PYR was low in the Gluc:gluconate mixture samples, and so the resulting 
isotopic profile could easily be software error (Fig. 20). As a confirmation of the isotopic 
patterns in the lower glycolytic metabolites, several amino acids were examined (Fig. 21). 
Alanine is derived from PYR, glycine is derived from alanine, valine is derived from the 
combination of two PYR molecules, and serine is derived from GAP; we therefore expected that 
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the alanine, glycine, and valine isotopic ratios would support the profiles observed in PYR, while 
serine would support the isotopic profile of DHAP. Acetyl-L-serine was used instead of serine 
because acetyl-L-serine is very stable, and had a strong peak in the samples.  
 
Figure 20. The quantification of several metabolites for the [U-
13
C]-Gluc condition (blue) and 
the equimolar [U-
13
C]-Gluc and unlabeled gluconate (purple) conditions. The quantifications 
shown are averages of the quantifications of OD600 readings 1 and 2. Gluconate was shown on a 
separate scale due to its overwhelming concentration per gCDW relative to the other metabolites. 
 
To confirm the isotopic distribution of PYR, the immediate downstream amino acids 
alanine and glycine were examined. The MAVEN signals for alanine and glycine were weak and 
choppy, indicating that these amino acids were not very prevalent in the samples. While the 
isotopic profile of alanine and glycine imply that PYR was completely triply 
13
C-labeled, none of 
these isotopic signatures are reliable (Fig. 19, 21). We next considered another immediate 
downstream metabolite from PYR, Ac-CoA. The isotopic profile of Ac-CoA was calculated 
using the isotopic profiles of citrate and aspartate (Fig. 21, 22). Since PYR undergoes a 
decarboxylation to form Ac-CoA, we expected the isotopic profile of Ac-CoA to reflect that of 
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PYR minus one isotopic label. Ac-CoA was calculated to be 84% doubly 
13
C-labeled, 7% singly 
13
C-labeled, and 9% nonlabeled (Fig. 21). This distribution indicated a PYR metabolite pool that 
was primarily triply 13C-labeled, but with a significant proportion of other isotopic moieties. 
Since the Ac-CoA distribution was based on two reliable sets of data, it is therefore likely that 
the original PYR isotopic profile overestimated the fraction of triply 
13
C-labeled PYR in this 
condition (Fig. 19, 21).  
 
Figure 21. The isotopic labeling fractions, with standard deviations, of select amino acids and 
Ac-CoA when grown on [U-
13
C]-Gluc and nonlabeled gluconate. The two columns for each 
metabolite represent the average isotopic labeling distribution at OD 1 (left) and OD 2 (right). 
Abbreviations used: (acetyl)-CoA, acetyl-coenzyme A 
 
As mentioned previously, it was important to discern if the PYR pool contained fractions 
of nonlabeled PYR, which could be evidence for the ED pathway. To obtain a clear, 
experimental picture of the PYR isotopes, valine was investigated, as it is a downstream 
metabolite from PYR. Valine is a five carbon metabolite and is synthesized by the combination 
of two PYR molecules, one of which undergoes a decarboxylation. Valine was 86% quintuply 
45 
 
13
C-labeled, which was likely predominantly derived from two triply 
13
C-labeled PYR (Fig. 21). 
This ratio supports the previously calculated 84% doubly 
13
C-labeled Ac-CoA, lending further 
evidence that PYR is likely ~85% triply 
13
C-labeled (Fig. 21). While not visibly discernable, 
valine was ~0.05% nonlabeled, which is too low of a value to be distinguishable from error in 
the software algorithm (Fig. 21). Since nonlabeled valine can only be produced from nonlabeled 
PYR (or a nonlabeled PYR and a specific singly 
13
C-labeled PYR), it was concluded that PYR 
lacked any nonlabeled moieties. The ED pathway splits a molecule of 6-PG in half to form a 
molecule of PYR and a molecule of GAP (Fig. 16). If the ED pathway were active, PYR would 
have an even greater fraction of nonlabeled moieties (derived from the 18-36% of nonlabeled 6-
PG) than it would have if it were derived from PEP (5-7% nonlabeled) (Fig. 16, 17, 19). Thus we 
can conclude that the ED pathway is not used in B. megaterium QM B1551 when fed a mixture 
of Gluc and gluconate. 
Phosphorylated metabolites tend to be unstable over time, and thus we sought 
confirmation of the isotopic profile of 3PG. In contrast with the 3PG data, acetyl-L-serine had a 
clean, strong peak in MAVEN. Acetyl-L-serine is synthesized from combining 3PG, a 
downstream metabolite of DHAP, and Ac-CoA. The isotopic profile of acetyl-L-serine consisted 
of ~70% quintuply 
13
C-labeled, 15% quadruply 
13
C-labeled, and 11% triply 
13
C-labeled isotopes 
(Fig. 21). Given that Ac-CoA was predominantly doubly 
13
C-labeled with some smaller fractions 
of singly 
13
C-labeled and nonlabeled moieties, the high fraction of quintuply, quadruply, and 
triply 
13
C-labeling in acetyl-L-serine corresponded to the primarily triply 
13
C-labeled and 
nonlabeled isotopes of 3PG combined with Ac-CoA (Fig. 19, 21). This result indicated that 
serine was derived from 3PG (Fig. 19, 21). 
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Figure 22. The isotopic labeling fractions, with standard deviations, for five intracellular 
metabolites in the TCA cycle when grown on [U-
13
C]-Gluc and nonlabeled gluconate. The two 
columns for each metabolite represent the average isotopic labeling distribution at OD 1 (left) 
and OD 2 (right). The abbreviation α-KG stands for α-ketoglutarate 
 
 The triply 
13
C-labeled PYR becomes incorporated into the TCA cycle either through a 
carboxylation reaction to become OAA, or through a decarboxylation reaction to form Ac-CoA 
(Fig. 16). The OAA isotopic labeling pattern was derived from the addition of nonlabeled or 
singly 
13
C-labeled CO2 with triply 
13
C-labeled pyruvate (Fig. 7, 16, 22). Indeed, the OAA 
labeling was determined via aspartate to be about 67% quadruply 
13
C-labeled and 24% triply 
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13
C-labeled (Fig. 22). Subsequent combination of OAA with doubly 
13
C-labeled acetyl moiety 
from Ac-CoA led to citrate labeling with 56% sextuply 
13
C-labeled and 25% quintuply 
13
C-
labeled (Fig. 21, 22). These proportions confirm that primarily labeled CO2 was incorporated. As 
before, malate and succinate showed an increased proportion of nonlabeled moieties (Fig. 22). 
Since the succinate and fumarate pools were comparable to those from the [U-
13
C]-Gluc 
condition, it was again hypothesized that there was a bottleneck in the flux from αKG to 
succinate, and from OAA to malate. Since there was an unlabeled substrate in this condition, 
additional experiments are needed to confirm that the increase in nonlabeled malate was not a 
result of gluconate incorporation into the TCA cycle. 
Comparing the Gluc and gluconate mixture condition to the Gluc alone condition, we 
noted that citrate was accumulated while both PYR and Ac-CoA were depleted (Fig. 20). 
Following previous reasoning, we suspect that PYR is rapidly depleted in this condition. This 
depletion could be due to a strong flux from pyruvate to the TCA cycle, or pyruvate to amino 
acid synthesis. The accumulation of citrate in the Gluc and gluconate condition supported the 
former theory, although further experiments will be needed to fully address this question (Fig. 
20).  
While the previous long-term isotopic enrichment experiments have suggested that B. 
megaterium QM B1551 could have a bifurcated TCA cycle, none of the experiments directly 
probed the TCA cycle. Thus, the bacterium was fed an equimolar carbon mixture of [U-
13
C]-
Gluc and unlabeled glutamate to ascertain how preferentially the amino acid would be used, if it 
would be incorporated as α-KG as predicted by the KEGG pathway, and if the TCA cycle was 
always bifurcated in this strain (Fig. 23). Any nonlabeled metabolite moieties would be derived 
from glutamate, while all fully 
13
C-labeled moieties would be derived from Gluc (Fig. 23). If 
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glutamate entered the metabolic network via α-KG, then α-KG should have a higher proportion 
of nonlabeled isotopes than any upstream metabolites like citrate or aconitate. Feeding a 
substrate directly into the TCA cycle should reveal if the TCA cycle is bifurcated under all 
conditions. 
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Figure 23. The theoretical isotopic distribution of the metabolic network of B. megaterium 
growing on [U-
13
C]-Gluc and unlabeled glutamate. The purple carbons are incorporated CO2. 
The green background shows the fate of the Ac-CoA atoms in the TCA cycle. The red 
background reiterates the position of the added CO2 when OAA is flipped prior to its acetylation.  
The faded reaction from isocitrate and αKG indicates that this flux was limited in this condition. 
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Figure 24. The isotopic labeling fractions, with standard deviations, for five intracellular 
metabolites in the glycolytic EMP pathway when grown on [U-
13
C]-Gluc and nonlabeled 
glutamate. The two columns for each metabolite represent the average isotopic labeling 
distribution at OD 1 (left) and OD 2 (right). Abbreviations used: G6P, glucose-6-phosphate; F6P, 
fructose-6-phosphate; 6PG, 6-phospho-gluconate; FBP, fructose-bis-phosphate 
 
Every metabolite in the EMP pathway was fully 
13
C-labeled, indicating that glutamate 
was not incorporated in this pathway and that all glycolytic metabolites were derived from 
glucose (Fig. 24). The same could be said for the PP pathway metabolites, excluding some error 
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in the first OD600 reading of S7P (Fig. 25). Interestingly, neither DHAP nor PEP had any 
nonlabeled moieties, yet PYR was approximately 7% nonlabeled (Fig. 26). This seems to 
indicate a partial backwards flux from OAA or malate to PYR, and a lack of further 
gluconeogenic flux (Fig. 23, 26, 27). 
 
 
Figure 25. The isotopic labeling fractions, with standard deviations, for three intracellular PP 
pathway metabolites when grown on [U-
13
C]-Gluc and nonlabeled glutamate. The two columns 
for each metabolite represent the average isotopic labeling distribution at OD 1 (left) and OD 2 
(right). Abbreviations used: R5P, ribose-5-phosphate; Xu5P, xyulose-5-phosphate; S7P, 
sedoheptulose-7-phosphate 
 
 
Figure 26. The isotopic labeling fractions, with standard deviations, for three intracellular, lower 
glycolytic, 3C metabolites when grown on [U-
13
C]-Gluc and nonlabeled glutamate. The two 
columns for each metabolite represent the average isotopic labeling distribution at OD 1 (left) 
and OD 2 (right). Abbreviations used: DHAP, dihydroxy-acetone-phosphate; PEP, 
phosphoenolpyruvate 
 
 Glutamate was incorporated into the metabolic network via αKG (Fig. 27). The 
metabolite αKG was 97% nonlabeled, which showed a large deviation in isotopic pattern relative 
to citrate’s 6% nonlabeled fraction (Fig. 27). To confirm that glutamate did not enter the 
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metabolic network upstream of αKG, the isotopic pattern of aconitate was examined (Fig. 28). At 
the first sampling point, aconitate was 50% nonlabeled; this fraction dropped to 15% nonlabeled 
by the second sampling point (Fig. 28). The isotopic distribution of aconitate at OD600 2 closely 
resembled that of citrate, although aconitate had a slightly higher proportion of nonlabeled 
fraction (Fig. 27, 28). This resemblance indicated that aconitate was derived from citrate, which 
in turn was predominantly derived from Gluc (Fig. 23, 27). In contrast, the large fraction of 
aconitate that was nonlabeled in the first OD600 sampling point seemed to indicate an early 
reversibility in the TCA cycle, as nonlabeled aconitate could only be derived from glutamate 
which did not pass through citrate (Fig. 27, 28). 
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Figure 27. The isotopic labeling fractions, with standard deviations, for six intracellular 
metabolites in the TCA cycle when grown on [U-
13
C]-Gluc and nonlabeled glutamate. The two 
columns for each metabolite represent the average isotopic labeling distribution at OD 1 (left) 
and OD 2 (right). The abbreviation αKG stands for α-ketoglutarate. 
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Figure 28. The isotopic labeling fractions, with standard deviations, for the metabolite aconitate 
when grown on [U-
13
C]-Gluc and nonlabeled glutamate. The two columns for each metabolite 
represent the average isotopic labeling distribution at OD 1 (left) and OD 2 (right). 
 
In the previous experiments, the isotopic profile of succinate was clearly derived from 
both the isotopic labeling of malate and αKG (Fig. 8, 14, 20). By contrast, the contribution from 
αKG to the succinate metabolite pool was overwhelming in the Gluc:glutamate condition (Fig. 
26). This could indicate that the influx of glutamate into the TCA cycle is overwhelming the 
bacterium, and effectively reprogramming the TCA cycle to capitalize on the abundant resource. 
We noted that the quadruply 
13
C-labeled and triply 
13
C-labeled fractions of malate and fumarate 
were clearly derived from OAA, and not from αKG; this flux from OAA to malate and fumarate 
was not as clearly implied in the other experiments (Figures 8, 14, 20). To investigate if the flux 
bottlenecks observed in the previous conditions persisted in the Gluc:glutamate mixture, key 
metabolite pools were quantified and compared to the Gluc alone condition (Fig. 29). The αKG 
pool was larger in the Gluc:glutamate condition than in the Gluc condition, indicating that there 
was a ready influx of substrate into the TCA cycle (Fig. 29). While both succinate and fumarate 
were more prevalent in the Gluc:glutamate condition, there was still a dramatic decrease in 
metabolite quantities between αKG and succinate, which clearly indicates a low flux between 
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these nodes (Fig. 29). It is also important to note that aspartate and citrate were less prevalent in 
the Gluc:glutamate condition than the Gluc condition, which supports the hypothesis that 
glutamate does not completely cycle through the TCA cycle (Fig. 29). 
 
Figure 29. The quantification of several metabolites for the [U-
13
C]-Gluc condition (blue) and 
the equimolar [U-
13
C]-Gluc and unlabeled glutamate condition (yellow). The quantifications 
shown are averages of the quantifications of OD600 readings 1 and 2. 
 
 On the whole, these long-term isotopic enrichment experiments revealed important flux 
relationships within the B. megaterium QM B1551 metabolic network. The oxidative PP 
pathway was preferentially used over the non-oxidative PP pathway; gluconate could be 
incorporated into the metabolic network when available; the TCA cycle was incompletely 
bifurcated; and gluconeogenesis occurred to a certain extent. 
 
 
 
56 
 
III. Hierarchical Sugar Metabolism 
 Following the confirmation of the metabolic network structure of Bacillus megaterium 
QM B1551, we investigated how the bacterium channels mixed-sugar substrates through its 
metabolic network. An equimolar carbon ratio of [1,2,3-
13
C]-Gluc, [1,6-
13
C]-Fruc, unlabeled Xyl 
was used to discern how each substrate was incorporated, and if any metabolites were derived 
preferentially from certain substrates (Fig. 30). These isotopes were chosen to maximize the 
distinctive isotopic profiles for as many key metabolites as possible. For example, metabolites 
derived from Gluc would have triply 
13
C-labeled moieties in the glycolytic pathway, and doubly 
13
C-labeled moieties in the pentose metabolites of the PP pathway (Fig. 30). Metabolites derived 
from Fruc would have doubly 
13
C-labeled moieties in the glycolytic pathway, and singly 
13
C-
labeled moieties in the pentose metabolites of the PP pathway (Fig. 30). Finally, metabolites 
derived from Xyl would be nonlabeled throughout the entire metabolic network (Fig. 30). This 
scheme was less effective at distinguishing from which substrate metabolites were derived with 
smaller metabolites like PYR, which could have nonlabeled isotopes from either [1,2,3-
13
C]-
Gluc or unlabeled Xyl; in cases like this, isotopic profiles of upstream metabolites were used to 
determine which substrate contributed more to the metabolite in question.  
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Figure 30. The theoretical isotopic distribution of the metabolic network of B. megaterium 
growing on [1,2,3-
13
C]-Gluc (black), [1,6-
13
C]-Fruc (blue), and unlabeled Xyl (red). The purple 
carbons are incorporated CO2. The green background shows the fate of the Ac-CoA atoms in the 
TCA cycle. The yellow background shows the carbons that are canonically cleaved in 
decarboxylation reaction from citrate to αKG. The blue background shows the carbons that are 
canonically cleaved in decarboxylation reaction from αKG to succinate. The red background 
reiterates the position of the added CO2 when OAA is flipped prior to its acetylation. 
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 Canonical bacterial metabolic databases have established that Gluc is incorporated into 
the metabolic network as G6P, Fruc is incorporated as FBP, and that Xyl is incorporated as 
pentose metabolites (Kanehisa and Goto, 2000; Kanehisa et al., 2017). Glycolytic metabolites 
derived from Gluc should be triply 
13
C-labeled in this scheme, while metabolites derived from 
Fruc or Xyl should be doubly 
13
C-labeled or nonlabeled, respectively. We found that G6P, 
gluconate, and 6-PG were approximately 70%, 90%, and 85% triply 
13
C-labeled, respectively 
(Fig. 30, 31). The next largest isotopic fraction for G6P and 6-PG was the doubly 
13
C-labeled 
moieties, at 16% and 10%, respectively (Fig. 31). The isotopic proportions of these metabolites 
indicated that Gluc was the preferred substrate for the upper glycolytic pathway in this mixed 
sugar condition, that Fruc was incorporated to some extent, and that Xyl was not used for the 
upper glycolytic pathway. These isotopic fractions further support the theory that gluconate was 
synthesized by B. megaterium QM B1551, because an 85% triply 
13
C-labeled 6-PG metabolite 
pool cannot be derived solely from a 70% triply 
13
C-labeled G6P metabolite pool (Fig. 31).  
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Figure 31. The isotopic labeling fractions, with standard deviations, for five metabolites in the 
glycolytic EMP pathway when grown on [1,2,3-
13
C]-Gluc, [1,6-
13
C]-Fruc, and nonlabeled Xyl. 
The two columns for each metabolite represent the average isotopic labeling distribution at OD 1 
(left) and OD 2 (right). Abbreviations used: G6P, glucose-6-phosphate; F6P, fructose-6-
phosphate; 6PG, 6-phospho-gluconate; FBP, fructose-bis-phosphate 
 
Based on our findings of the metabolic network of B. megaterium, we expected to see a 
large flux through the oxidative PP pathway; pentose phosphate metabolites derived from Gluc 
would be largely doubly 
13
C-labeled if synthesized through the oxidative PP pathway, and 
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largely triply or doubly 
13
C-labeled if synthesized through the nonoxidative PP pathway. These 
same metabolites would be singly 13C-labeled if synthesized through either the oxidative or 
nonoxidative PP pathway if derived from Fruc. Similarly, all the pentose phosphate metabolites 
should be primarily nonlabeled if derived from Xyl. We found that R5P and Xu5P were 60% 
doubly 
13
C-labeled, 16% triply 
13
C-labeled, 9% singly 
13
C-labeled, and 5% nonlabeled (Fig. 32). 
The highest isotopic fraction of the pentose metabolites was doubly 13C-labeled moieties, which 
suggests that the oxidative PP pathway was more active than the nonoxidative PP pathway, and 
that Gluc was the preferred substrate for the PP pathway. The labeling patterns showed minimal 
incorporation of Xyl, both in the PP pathway and throughout the metabolic network, indicating 
that in the presence of Gluc and Fruc, B. megaterium QM B1551 had minimal uptake of Xyl 
(Fig. 31, 32). Thus, from this point forward, Xyl will not be considered as a significant carbon 
source from the mixture unless stated otherwise. 
 
Figure 32. The isotopic labeling fractions, with standard deviations, for three PP pathway 
metabolites when grown on [1,2,3-
13
C]-Gluc, [1,6-
13
C]-Fruc, and nonlabeled Xyl. The two 
columns for each metabolite represent the average isotopic labeling distribution at OD 1 (left) 
and OD 2 (right). Abbreviations used: R5P, ribose-5-phosphate; Xu5P, xyulose-5-phosphate; 
S7P, sedoheptulose-7-phosphate 
 
The other glycolytic metabolites, F6P and FBP, contained ~43% and 32% triply 
13
C-
labeled fractions, respectively (Fig. 31). This indicated that Gluc was incorporated to a 
significant degree throughout the glycolytic pathway. Similarly, Fruc was incorporated into the 
metabolic network similarly as Gluc in the metabolites F6P and FBP (~41% and 23% doubly 
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13
C-labeled, respectively) (Fig. 31). A high fraction of doubly 
13
C-labeled FBP would be 
expected if Fruc was entering the network through this node, and a high fraction of doubly 
13
C-
labeled F6P could indicate a strong flux from FBP to F6P. Alternatively, doubly 
13
C-labeled F6P 
can be derived from a transketolase reaction from the PP pathway, and thus additional metabolite 
information is needed to elucidate the exact contribution of Fruc and Gluc to these metabolic 
nodes.  
 
Figure 33. The isotopic labeling fractions, with standard deviations, for three lower glycolytic 3C 
metabolites when grown on [1,2,3-
13
C]-Gluc, [1,6-
13
C]-Fruc, and nonlabeled Xyl. The two 
columns for each metabolite represent the average isotopic labeling distribution at OD 1 (left) 
and OD 2 (right). Abbreviations used: DHAP, dihydroxy-acetone-phosphate; PEP, 
phosphoenolpyruvate 
 
 As products of the aforementioned labeling patterns in the glycolytic and PP pathways, 
the three-carbon metabolites have roughly equal proportions of nonlabeled, singly 
13
C-labeled, 
and triply 
13
C-labeled moieties (Fig. 33). The splitting of triply 
13
C-labeled FBP (derived from 
the labeled Gluc substrate) would result in a triply 
13
C-labeled DHAP and a nonlabeled GAP, 
which would rapidly exchange (Fig. 30). The splitting of doubly 
13
C-labeled FBP (derived from 
the labeled Fruc substrate) would result in a singly 
13
C-labeled DHAP and a singly 
13
C-labeled 
GAP (Fig. 30). The ratio of nonlabeled, singly 
13
C-labeled, and triply 
13
C-labeled fractions (36%, 
34%, and 29% respectively for DHAP) were similar, thus implying that Gluc contributed twice 
as much as Fruc to the isotopic profiles of the three-carbon metabolite (Fig. 33). It is also 
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possible that Xyl made a small contribution to these metabolites (Fig. 33). Gluconeogenic flux 
through the combination of DHAP and GAP to make FBP led to sextuply 
13
C-labeled (6.5%), 
quadruply 
13
C-labeled (15%), singly 
13
C-labeled (14%), and nonlabeled (6%) FBP moieties (Fig. 
31). The gluconeogenic flux did not extend beyond FBP, as F6P and G6P had minimal quantities 
of these isotopic fractions (Fig. 31). 
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Figure 34. The isotopic labeling fractions, with standard deviations, for six metabolites in the 
TCA cycle when grown on [1,2,3-
13
C]-Gluc, [1,6-
13
C]-Fruc, and nonlabeled Xyl. The two 
columns for each metabolite represent the average isotopic labeling distribution at OD 1 (left) 
and OD 2 (right). The abbreviation α-KG stands for α-ketoglutarate. 
  
 Proceeding into the TCA cycle, PYR could either combine with CO2 to produce the 
isotopic patterns seen in OAA, or undergo a decarboxylation that yielded primarily nonlabeled or 
doubly 
13
C-labeled Ac-CoA (Fig. 30, 33). In this sugar mixture condition, the local CO2 was 
~50% nonlabeled (Fig. 7).  We therefore predicted OAA would be primarily singly 
13
C-labeled, 
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followed by roughly equal fractions of nonlabeled, doubly
13
C-labeled, triply
13
C-labeled, and 
quadruply 
13
C-labeled OAA moieties. The isotopic proportions of the OAA pool were 33% 
singly 
13
C-labeled, 21% nonlabeled, 17% doubly 
13
C-labeled, 18%% triply 
13
C-labeled, and 9% 
quadruply 
13
C-labeled (Fig. 34). These fractions aligned well with our predictions, although the 
smaller fraction of quadruply 
13
C-labeled OAA could indicate a slightly higher fraction of 
nonlabeled CO2 than predicted (Fig. 7, 34).  
Moving forward in the cycle, OAA was combined with Ac-CoA to form citrate, which 
was then decarboxylated to form α-KG (Fig. 30). The isotopic proportions of OAA, citrate, and 
α-KG were all relatively similar and followed patterns predicted by the labeling scheme (Fig. 30, 
34). Once α-KG had decarboxylated to succinate, however, the predicted patterns were no longer 
measured (Fig. 30, 34). There was an increase in the nonlabeled fraction of succinate, and the 
relative isotopic fractions of the succinate pool varied slightly between OD600 1 and 2 (Fig. 34). 
This increase in nonlabeled moieties was also seen in the malate and fumarate metabolite pools, 
both of which exhibited instability in isotopic fractions over sampling points (Fig. 34). As 
discussed before, to ascertain if these metabolites were correctly fractionated by MAVEN, the 
quantities of several metabolites were found and compared to the Gluc alone condition (Fig. 35). 
Every metabolite quantified in the mixed sugar condition was either comparable or depleted 
relative to the Gluc alone condition (Fig. 35). As seen previously, there was a substantial 
bottleneck between citrate and α-KG, and between α-KG and succinate (Fig. 35). These 
bottlenecks were less pronounced in the mixed sugar condition (Fig. 35). Fumarate was not 
significantly produced in this condition, which indicated that the bottleneck from OAA to malate 
and fumarate was also present (Fig. 34, 35). While we suspect that the increase in nonlabeled 
succinate fraction was a result of the bottleneck to this node, there was a source of unlabeled 
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substrate in this sugar mixture. Therefore, more experiments would need to be performed to 
verify that Xyl was not the source of the nonlabeled TCA cycle metabolites. 
 
Figure 35. The quantification of several metabolites for the [U-
13
C]-Gluc condition (blue) and 
the equimolar [1,2,3-
13
C]-Gluc, [1,6-
13
C]-Fruc, and unlabeled Xyl condition (green). The 
quantifications shown are averages of the quantifications of OD600 readings 1 and 2. 
 
  
IV. Metabolic Flux Analysis 
 The MFA model was based on B. megaterium QM B1551 growing on Gluc alone, and 
was constrained using the Gluc consumption rate, Gluc-specific metabolite secretion rates, Gluc-
specific growth rate, and biomass growth. The model served as a diagnostic tool for predicting 
which reaction pathways were used in the metabolic network. 
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Figure 36. A model of metabolic fluxes in B. megaterium QM B1551, normalized to the 
consumption rate of [1,2-
13
C]-Gluc. The values listed in blue next to each reaction are the 
predicted fluxes as a percentage of the influx of Gluc. The red arrows and the values listed in red 
represent outflows from the metabolic network, and indicate the flux towards excretion and/or 
biomass. All fluxes were averaged from the optimal fluxes derived from running the model with 
two biological replicates at OD600 2. The standard deviation for some TCA cycle fluxes were 
shown to explain that the small fluxes did not add correctly because of their large errors. 
 
 The resulting MFA model was compared to a previous model to analyze how the 
metabolomics approach altered the predicted fluxes from an amino acid-based approach. In 
particular, the metabolic flux network of B. megaterium MS941 from Furch et al. (2007a) was 
used as a basis of comparison. The calculated fluxes in the upper glycolytic cycle closely 
matched those previously reported (Furch et al., 2007). In the PP pathway, however, the flux 
from Xu5P and E4P towards F6P and GAP was found to be about 8% in this model, while it had 
previously been reported within the range of 32 to 46% (Fig. 36; Furch et al., 2007a). This 
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dramatic decrease in predicted flux was likely due to the type of experimental data used by both 
models. Due to the resolution limitations with amino acid labeling, the R5P and Xu5P nodes 
were treated as a single P5P node in the Furch et al. model (2007a). Consequently, the P5P node 
had inputs for both R5P and Xu5P, which were balanced by a necessarily large efflux from P5P 
(Furch et al., 2007a). Thus, the flux from P5P and E4P towards F6P and GAP was bounded by 
the large influx to both R5P and Xu5P in that model (Furch et al., 2007a). The metabolomics 
method was able to resolve both Xu5P and R5P, and thus the flux from Xu5P and E4P was 
constrained by the flux from Ru5P to Xu5P, as well as the other outward fluxes from these nodes 
(Fig. 36). Since the flux from Ru5P to Xu5P was approximately half of the flux predicted from 
the Furch et al. (2007a) model, the flux from Xu5P and E4P towards F6P and GAP was forced to 
be only 8% (Fig. 36). Due to an overestimation of flux into the P5P metabolites, the previous 
model overestimated the flux out from the PP pathway (Furch et al., 2007a). 
 This single overestimation from the amino acid method had significant downstream 
implications in the Furch et al. model (2007a). Our calculated model also predicted that the 
fluxes into the lower glycolytic pathway would between 110 to 140%, whereas the Furch et al. 
(2007a) model predicted that these same fluxes would range from 142 to 194%. This increase in 
predicted fluxes can be traced directly to the overestimation in the PP pathway flux, which 
contributed to the GAP node (Fig. 36). The incremental decrease in flux between each three-
carbon node was a result of large biomass efflux from these metabolites, and was similarly 
reflected in the Furch et al. (2007a) model (Fig. 36). This similarity was expected, as both the 
metabolomics model and the amino acid model were constructed using the stoichiometric 
biomass composition from Dauner et al., 2001b. 
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 The calculated fluxes from PYR towards Ac-CoA and OAA summed to 67.5%, whereas 
the previous model reported a flux of 184% (Furch et al., 2007a). The difference between these 
fluxes is over an order of magnitude, and cannot be accounted for solely by the earlier PP 
pathway flux overestimation. Furch et al. (2007a) reported a 68% flux from malate to PYR, 
whereas our model predicted this flux would be 0% (Fig. 36). Based on the previous analysis of 
the long-term isotopic enrichments, it was concluded that malate was not synthesized in large 
quantities in this bacterial species. A flux of 68% from malate to PYR by Furch et al. (2007a) 
would require a significant flux into malate from either fumarate or OAA, neither of which was 
consistent with our metabolomics data nor our MFA analysis. This overestimation in the reported 
model could again be a result of the resolution in the metabolite labeling patterns in the previous 
study. The TCA cycle of the Furch et al. (2007a) model consisted of only three nodes: malate, 
OAA, and a lumped term for organic acids. The organic acids were assumed to encompass 
citrate, αKG, succinate, and fumarate. We have captured substantial bottlenecks in the fluxes 
between each of these nodes in our model, but these constricting fluxes were likely masked by 
the summation across the organic acid nodes in the Furch et al. (2007a) model. In our model, we 
had a substantial efflux towards biomass and secretion from αKG, which resulted in fluxes 
smaller than 3% for the rest of the TCA cycle (Fig. 36). While Furch et al. (2007a) also included 
a substantial efflux from the organic acids in their model, the aforementioned overestimation of 
fluxes upstream of the TCA cycle resulted in a greater flux into the TCA cycle (Furch et al., 
2007a). As such, Furch et al. (2007a) had excess flux in the TCA cycle that was balanced by 
excess flux from the organic acids towards malate, and then back towards PYR. Given that the 
long-term isotopic enrichment data did not support these predictions, the previously reported 
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model was insufficient to accurately predict the balance of fluxes in this section of the B. 
megaterium metabolic network.   
 
V. Kinetics 
 To observe the in vivo incorporation of isotopically 
13
C-labeled carbon into B. 
megaterium QM B1551, and thus provide an independent experimental comparison for the 
fluxes predicted by the MFA, kinetic isotopic experiments were performed. The kinetic 
experiments were performed using [U-
13
C]-Gluc as a control, and an equimolar mixture of [U-
13
C]-Gluc and unlabeled glutamate. These experiments allowed us to visualize the in vivo 
changes in metabolic fluxes. Given the previous observations from the long-term isotopic 
enrichment experiments, we expected to see a faster rate of labeled isotopic incorporation in the 
glycolytic pathway for the Gluc condition, and a slower rate in the TCA cycle for the 
Gluc:glutamate condition. 
From the experimental setup, glutamate incorporation into the metabolic network would 
result in stable nonlabeled metabolite fractions. By contrast, Gluc incorporation would result in 
an increase in 
13
C-labeled metabolite fractions. According to the long-term enrichment data, 
glutamate-derived nonlabeled carbons were not incorporated into the glycolytic or PP pathway 
pathways beyond a fractional contribution to the PYR node (Fig. 26, 37). We examined the in 
vivo kinetic incorporation of both glucose-derived 
13
C-labeled carbons and glutamate-derived 
nonlabeled carbons on five glycolytic or pentose metabolites, as well as the TCA cycle 
metabolites (Fig. 37, 38, 39). The impact of the two conditions on these metabolites were 
compared based on the initial rate of isotopic incorporation (the initial slope of the kinetics 
curves), the fraction of isotopic incorporation after 30 minutes (the asymptotic part of the 
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kinetics curves), and the final fraction of isotopic incorporation (the pseudo-steady state isotopic 
fractions). 
The initial rate of isotopic assimilation appeared to be lower in the mixed condition than 
in the Gluc alone condition for all glycolytic and PP pathway metabolites except gluconate (Fig. 
37). This indicated that the presence of glutamate in the metabolic network dampened the 
catabolism of Gluc, even in metabolic nodes that were distant from the uptake site of glutamate 
(Fig. 23, 37). The fraction of fully 
13
C-labeled isotopes was higher in the Gluc alone condition at 
all time points tested for G6P, FBP, DHAP, and Xu5P, which indicated that glutamate 
consistently inhibited the catabolism of Gluc during early exponential growth (Fig. 37). The 
sharp curvature of the gluconate samples could be a result of MAVEN insensitivity at low 
metabolite concentrations (Fig. 37). Gluconate is produced in greater quantities in the Gluc and 
glutamate condition than in the Gluc alone condition (Fig. 29). Thus, the observed rate of 
isotopic incorporation for gluconate for the Gluc alone condition is likely inaccurate, since it is 
difficult to measure the rate associated with a very low-level metabolite pool.  
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Figure 37. The dynamic changes in the isotopic proportions of G6P, gluconate, FBP, Xu5P, and 
DHAP for [U-
13
C]-Gluc (left kinetics) and [U-
13
C]-Gluc unlabeled Glutamate (right kinetics). 
Any isotopic fraction that was less than 10% for the entire 30 minutes was omitted for clarity. 
All standard deviations of both sets of kinetics data were less than 5%. The long-term isotopic 
enrichments for [U-
13
C]-Gluc (left long-term) and [U-
13
C]-Gluc and unlabeled glutamate (right 
long-term) show the final proportions of the labeled fractions of these metabolites at OD600 1 and 
2.  
 
After 30 minutes, the proportion of fully 
13
C-labeled metabolites was ~20% less for G6P, 
FBP, Xu5P, and DHAP in the Gluc and glutamate experiment than in the Gluc experiment (Fig. 
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37). However, the long-term isotopic enrichment of these metabolites in both experimental 
conditions resulted in nearly 100% fully 
13
C-labeled metabolic pools (Fig. 37). This observation 
indicated that the time needed to reach pseudo-steady state for isotopic incorporation in B. 
megaterium QM B1551 was dependent on the nutritional conditions. In our case, the presence of 
glutamate seemed to slow down the synthesis of glycolytic and pentose phosphate metabolites, 
thereby preventing them from reaching pseudo-steady state as quickly as in the Gluc alone (Fig. 
37). 
 The final three-carbon metabolite, PYR, displayed similar labeling kinetics as DHAP for 
the kinetic incorporation of 
13
C-labeled fractions (Fig. 38). As before, the initial rate of isotopic 
assimilation appeared to be lower in the mixed condition than in the Gluc alone condition, and 
the identical isotopic proportions of DHAP and PYR were similar at each time point (Fig. 37, 
38). This indicated that PYR was not synthesized as readily from Gluc in the Gluc and glutamate 
condition as in the Gluc alone condition. This observation, along with those from the glycolytic 
and PP pathways, implied a transient cellular preference for glutamate during initial growth, 
followed by a preference for Gluc after ~12 minutes (Fig. 37, 38). The initial preference for 
glutamate over Gluc was shown by the decreased rate of initial 
13
C-labeled metabolite 
assimilation in the early time points in the Gluc and glutamate condition relative to the Gluc 
alone condition (Fig. 37, 38). The long-term enrichment experiments revealed that a small 
nonlabeled fraction persisted in the PYR metabolite pool, while none persisted in the DHAP 
metabolite pool (Fig. 38). Thus, the kinetic labeling data was insufficient to determine which 
metabolites were populated via gluconeogenic fluxes.  
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Figure 38. The time-dependent changes in the proportions of labeled fractions of pyruvate, 
aspartate, and citrate for [U-
13
C]-Gluc (left kinetics) and [U-
13
C]-Gluc: nonlabeled Glutamate 
(right kinetics). Any labeled fraction that was less than 10% for the entire 30 minutes was 
omitted from the kinetics graphs for clarity. All standard deviations of both sets of kinetics data 
were less than 5%. The long-term isotopic enrichments for [U-
13
C]-Gluc (left long-term) and [U-
13
C]-Gluc: nonlabeled Glutamate (right long-term) show the final proportions of the labeled 
fractions of these metabolites at OD600 1 and 2. Note that the colors used for the kinetics legend 
correspond with every graph, while the shapes of the points may vary. 
  
 The most dramatic impacts of glutamate incorporation on metabolic labeling kinetics 
were seen in the TCA cycle (Fig. 38). It has been observed that OAA (deduced from aspartate 
labeling) was likely derived from PYR, because the two metabolites typically shared similar 
isotopic profiles. The initial rate of isotopic incorporation into aspartate was lower in the Gluc 
and glutamate condition than in the Gluc alone condition (Fig. 38). In the Gluc alone condition, 
aspartate was populated first by triply 
13
C-labeled carbons (1 min) before being primarily 
populated by quadruply 
13
C-labeled carbons (12 min) (Fig. 38). These isotopes reflected the 
isotopic profile of PYR combined first with nonlabeled CO2 and then with fully 
13
C-labeled CO2, 
respectively (Fig. 38). By contrast, the largest fraction of aspartate in the Gluc and glutamate 
condition was still nonlabeled after 30 minutes (Fig. 38). These two findings implied that 
aspartate is derived preferentially from glutamate during early stages of growth (Fig. 38). The 
long-term isotopic enrichment experiment revealed that the pseudo-steady state fraction of 
nonlabeled aspartate was significantly higher in the mixed condition than the Gluc alone 
condition, which implied that while the flux of glucose-derived 
13
C-labeled carbons to OAA did 
eventually increase, there was a persistently strong flux of glutamate-derived 
13
C-labeled carbons 
to OAA (Fig. 38). Thus the TCA cycle was reprogrammed in the presence of glutamate, and the 
TCA cycle of B. megaterium QM B1551 was not completely bifurcated in all substrate 
conditions. 
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The citrate labeling kinetics provided further evidence of an initial preferential uptake of 
glutamate. The initial rate of isotopic incorporation was decreased in for citrate in the mixed 
condition relative to the Gluc alone condition (Fig. 38). As the fraction of nonlabeled citrate was 
depleted, the fraction of doubly 
13
C-labeled citrate remained the highest isotopically labeled 
fraction throughout the 30 minute time course (Fig. 38). Since OAA was minimally doubly 
13
C-
labeled throughout the growth of the bacterium, doubly 
13
C-labeled citrate could only be derived 
from nonlabeled OAA and doubly 
13
C-labeled Ac-CoA (Fig. 23, 38). Thus, in the first 30 
minutes of the mixed condition, citrate was derived from a TCA cycle that was primarily 
populated with glutamate-derived nonlabeled carbons, as well as from the lower glycolytic 
pathway which was populated primarily with glucose-derived 
13
C-labeled carbons. This 
confirmed that for at least the first 30 minutes of growth, glutamate populated the TCA cycle 
while Gluc populated the glycolytic and PP pathways. The fraction of sextuply 
13
C-labeled 
citrate was ~25% after 30 minutes of growth, but increased to ~40% at pseudo-steady state (Fig. 
38). As before, this indicated that there was an early substrate preference for glutamate, followed 
by a preference for Gluc. 
The strongest influx of glutamate into the metabolic network occurred in the αKG node 
(Fig. 39). Both the initial rate of isotopic incorporation and the fraction of incorporation over the 
30 minute time course were lower in the mixed condition than in the Gluc alone condition (Fig. 
39). Indeed, the αKG metabolite pool had a greater than 90% nonlabeled fraction over the first 
30 minutes of growth in the mixed condition, and the pseudo-steady state isotopic profile of 
αKG was nearly 100% nonlabeled (Fig. 39). These results implied a minimal influx of glucose-
derived 
13
C-labeled carbons into this metabolite; by extension, the results implied a bifurcation 
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of the TCA cycle, as the flux from glutamate to αKG overpowered any flux from citrate to αKG 
(Fig. 23, 39).  
Since succinate was immediately downstream from αKG, it received minimal input from 
Gluc catabolism through the classical clockwise reactions of the TCA cycle (Fig. 23, 39). 
Fumarate and malate both had significant proportions of quadruply 
13
C-labeled and triply 
13
C-
labeled fractions during the kinetic labeling experiment, and even greater proportions of these 
isotopic fractions at pseudo-steady state (Fig. 39). This indicated that fumarate and malate were 
partly populated by glucose-derived 
13
C-labeled carbons from OAA (Fig 38, 39). We noted that 
in contrast to the other metabolites, fumarate had a greater rate of initial isotopic incorporation in 
the Gluc and glutamate mixture than the Gluc alone condition (Fig. 39). In the Gluc alone 
labeling kinetics, the fraction of nonlabeled fumarate did not drop below 90% for the first 30 
minutes, indicating that there was minimal isotopic incorporation into fumarate and that fumarate 
was not synthesized (Fig. 39). The larger pool size of fumarate in the Gluc and glutamate 
condition indicated that fumarate was synthesized in this condition, and thus the increased initial 
rate of isotopic incorporation for fumarate in the mixed condition was a reflection of the 
increased presence of this metabolite (Fig. 29, 39). Since succinate did not have significant 
proportions of glucose-derived 
13
C-labeled carbons either during the 30 minute kinetic labeling 
time course or at pseudo-steady state, there was no flux from fumarate to succinate in this 
condition (Fig. 39). However, the increase in the nonlabeled fraction of the kinetic labeling data 
of malate in the mixed substrate condition compared to the Gluc alone condition implied that 
there was a net flux of glutamate-derived nonlabeled carbons from succinate to fumarate, and 
from fumarate to malate (Fig. 39). Thus, B. megaterium QM B1551 can employ the full TCA 
cycle when necessary (Fig. 29).  
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The above analysis implied not only reversibility in the TCA cycle from (OAA to malate, 
and from malate to fumarate), but also a bottleneck in the flux from citrate to αKG, and a 
bottleneck in the flux from succinate to fumarate. Fumarate was only two nodes distant from 
αKG in the metabolic network, so it should have experienced the same overwhelming input of 
glutamate-derived nonlabeled carbon as succinate (Fig. 23). By contrast, fumarate and malate 
were ~70% nonlabeled at pseudo-steady state, which implied a low flux from succinate to 
fumarate. This hypothesis was verified by the metabolic pool sizes; even when the size of the 
αKG and succinate pools were increased drastically relative to the Gluc condition, the increase in 
the size of the fumarate pool was minimal, and the citrate and aspartate pool sizes were 
comparable between Gluc and Gluc:glutamate conditions (Fig. 29). Thus, the kinetic data and the 
metabolite quantifications prove that even with substrate influx directly into the TCA cycle, the 
fluxes between the TCA cycle metabolites were very low, partially bifurcating the TCA cycle. 
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Figure 39. The time-dependent changes in the proportions of labeled fractions of αKG, succinate, 
fumarate, and malate for [U-
13
C]-Gluc (left kinetics) and [U-
13
C]-Gluc: nonlabeled Glutamate 
(right kinetics). Any labeled fraction that was less than 10% for the entire 30 minutes was 
omitted from the kinetics graphs for clarity. All standard deviations of both sets of kinetics data 
were less than 5%. The long-term isotopic enrichments for [U-
13
C]-Gluc (left long-term) and [U-
13
C]-Gluc: nonlabeled Glutamate (right long-term) show the final proportions of the labeled 
fractions of these metabolites at OD600 1 and 2. Note that the colors used for the kinetics legend 
correspond with every graph, while the shapes of the points may vary. Abbreviation used: αKG, 
alpha-ketoglutarate 
 
To ascertain that glutamate was truly entering the TCA cycle through αKG and not an 
upstream metabolite, the kinetic carbon incorporation of aconitate was monitored (Fig. 40). In 
the Gluc alone condition, the aconitate metabolite pool was rapidly populated with 
13
C-labeled 
isotopes (Fig. 40); in the Gluc and glutamate condition, however, the incorporation kinetics 
resembled those of aspartate, in which the nonlabeled fraction was still dominant at the end of 30 
minutes (Fig. 38, 40). Aconitate is an intermediate node between citrate and αKG, and while the 
decrease in nonlabeled was clearly greater in aconitate than in αKG, the decrease in nonlabeled 
in citrate was greater than in aconitate (Fig. 38, S4, 40). By minute 4, the fraction of nonlabeled 
citrate was 30%, but the fraction of nonlabeled aconitate was ~60% (Fig. 38, 40). Since αKG is 
presumed to have no flux backwards through the TCA cycle, no glutamate-derived nonlabeled 
carbons can flow to aconitate without passing through citrate. Therefore, the slower 
incorporation of 
13
C-labeled carbon in aconitate than in citrate implied a decreased flux from 
citrate to aconitate, in agreement the previously observed bottleneck of citrate from the long-term 
enrichment experiments. 
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Figure 40. The time-dependent changes in the proportions of labeled fractions of aconitate, 
ornithine, and citrulline for [U-
13
C]-Gluc (left kinetics) and [U-
13
C]-Gluc: nonlabeled Glutamate 
(right kinetics). Any labeled fraction that was less than 10% for the entire 30 minutes was 
omitted from the kinetics graphs for clarity. All standard deviations of both sets of kinetics data 
were less than 5%. The long-term isotopic enrichments for [U-
13
C]-Gluc (left long-term) and [U-
13
C]-Gluc: nonlabeled Glutamate (right long-term) show the final proportions of the labeled 
fractions of these metabolites at OD600 1 and 2. Note that the colors used for the kinetics legend 
correspond with every graph, while the shapes of the points may vary.  
 
In conclusion, these experiments have shed light on several aspects of the metabolic 
network of B. megaterium not previously reported. Metabolite quantifications showed that while 
gluconate was not synthesized in large quantities by this bacterium, gluconate can be 
incorporated into the metabolic network to a significant extent when present in the environment. 
This finding holds implications for future modeling efforts, as it lends support to the 
simplification of the metabolic network via gluconate omission while also cautioning the 
modelers to be mindful of the environmental conditions. It was evident in every long-term 
isotopic enrichment experiment that the TCA cycle is bifurcated, although the Gluc and 
glutamate trial proved that the TCA cycle can still function in its entirety when provided a direct 
influx of substrate. The MFA model supported the conclusion that the TCA cycle of B. 
megaterium QM B1551 was incompletely bifurcated. The kinetic experiments independently 
supported the TCA cycle bifurcation conclusion as well as the MFA model, as the dynamic 
incorporation of carbon into the TCA cycle metabolites succinate, fumarate, and malate was very 
low, even in the presence of glutamate. These same experiments demonstrated that B. 
megaterium can have temporal and sectional preferences for substrates; glutamate was 
incorporated into the TCA cycle extensively early in the exponential growth phase, while Gluc 
was preferentially incorporated into the glycolytic and PP pathways independent of time. Finally, 
long-term isotopic enrichment using a mixture of Gluc, Fruc, and Xyl revealed hierarchical sugar 
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preferences of B. megaterium QM B1551; the bacterium consumed Gluc and Fruc more or less 
equally, and Xyl was minimally incorporated when these hexose sugars were present. 
For the future direction of this project, additional MFA models for each mixed substrate 
condition would further elucidate how the metabolic network changes in response to different 
carbon sources. Similarly, additional kinetic experiments on mixed substrate conditions would 
provide essential evidence and verification for the MFA models. These two efforts will help 
direct this research towards a better understanding of how B. megaterium regulates its metabolic 
network, which will in turn allow for optimized industrial use of this bacterium. 
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Appendix 
 
 
Figure S1. The individual growth curves for each experimental condition; Gluc (blue), Fruc 
(green), Xyl (red), Gluc:Fruc:Xyl (light blue), and Gluc:Glutamate (orange). These curves were 
used to plan subsequent experiments which required timing of bacterial growth. The growth rates 
were obtained during the gCDW experiments. 
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Figure S2. The average Peak Area Top of each metabolite and each experimental condition. The 
pool size for gluconate in the Gluc:Gluconate experiment (2.05*10
9
) was omitted for scaling 
purposes. Abbreviations used: G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; FBP, 
fructose-bis-phosphate; R5P, ribose-5-phosphate; Xu5P, xyulose-5-phosphate; S7P, 
sedoheptulose-7-phosphate 
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Table S1. The MFA output of each metabolic reaction, the flux value, and the standard deviation 
of the flux value. The reactions and fluxes shown in red are either secretions or biomass effluxes 
from the identified node. The values in blue represent the values seen in Fig. 36.  
Reaction Flux Value (%) Standard Dev (%) 
BM_AKG 17.7017 4.3E-05 
BM_E4P 5.45478 1.2288 
BM_OAA 19.7679 6.7E-05 
BM_PEP 12.9945 1.02541 
BM_PG3 22.477 0.51813 
BM_PYR 43.2077 0.03195 
BM_R5P 13.5387 4.9E-05 
BM_AcCoA 9.54686 0.00092 
Ex_Fum 0.0613 0.04144 
Ex_Cit 0.24509 6.6E-05 
BM_G6P 3.88292 0.00026 
Ex_Glucn 0.11924 0.00023 
Ex_Succ 0.87513 0.4325 
OAA -> Fum 0.96412 1.36339 
Mal -> Pyr + CO2 0.00012 6.7E-05 
G6P -> 6PG 48.2079 0.00017 
G6P -> F6P 47.7893 1.74685 
FBP -> DHAP + GAP 69.0843 1.33706 
GAP -> PG3 146.089 1.85482 
PG3 -> PEP 123.612 2.37294 
PEP -> Pyr 110.617 1.3476 
DHAP -> GAP 69.0843 1.33706 
Glucperi -> Glucn 0.1198 0.0004 
F6P -> FBP 69.0843 1.33706 
6PG →Ru5P 48.2085 0.00034 
Ru5P -> R5P 26.9135 0.40945 
Ru5P -> X5P 21.295 0.40979 
X5P + R5P -> GAP + S7P 13.3749 0.4095 
GAP + S7P -> E4P + F6P 13.3749 0.4095 
E4P + X5P -> F6P + GAP 7.92009 0.8193 
Pyr -> AcCoA + CO2 28.7584 1.78936 
Pyr + CO2 -> OAA 38.6514 0.47364 
OAA -> PEP + CO2 0.0002 6.7E-05 
OAA + AcCoA -> Cit 19.2115 1.78843 
Cit -> αKG 18.9664 1.78837 
αKG -> Succ  + CO2 1.26473 1.78833 
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Succ -> Fum 0.3896 1.11042 
Fum -> Mal 1.3377 1.78082 
Mal -> OAA 2.89212 1.36312 
Gluc -> Glucperi 100 1.74602 
Glucperi -> G6P 99.8802 1.74642 
Glucnperi -> 6PG 0.00056 0.00017 
 
